株探米国株
日本語 英語
エドガーで原本を確認する
000032033512/312023Q1FALSEhttp://www.globelifeinsurance.com/20230331#RealizedInvestmentGainsLossesAndGainLossOnExtinguishmentOfDebthttp://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParenthttp://www.globelifeinsurance.com/20230331#RealizedInvestmentGainsLossesAndGainLossOnExtinguishmentOfDebthttp://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent00003203352023-01-012023-03-310000320335us-gaap:CommonStockMember2023-01-012023-03-310000320335gl:JuniorSubordinatedDebenturesMember2023-01-012023-03-3100003203352023-04-28xbrli:shares00003203352023-03-31iso4217:USD00003203352022-12-310000320335gl:PartnershipInterestFairValueOptionMembersrt:PartnershipInterestMember2023-03-310000320335gl:PartnershipInterestFairValueOptionMembersrt:PartnershipInterestMember2022-12-31iso4217:USDxbrli:shares0000320335us-gaap:LifeInsuranceSegmentMember2023-01-012023-03-310000320335us-gaap:LifeInsuranceSegmentMember2022-01-012022-03-310000320335us-gaap:HealthInsuranceProductLineMember2023-01-012023-03-310000320335us-gaap:HealthInsuranceProductLineMember2022-01-012022-03-310000320335us-gaap:OtherInsuranceProductLineMember2023-01-012023-03-310000320335us-gaap:OtherInsuranceProductLineMember2022-01-012022-03-3100003203352022-01-012022-03-310000320335gl:SecuritiesMember2023-01-012023-03-310000320335gl:SecuritiesMember2022-01-012022-03-310000320335us-gaap:PreferredStockMember2022-12-310000320335us-gaap:CommonStockMember2022-12-310000320335us-gaap:AdditionalPaidInCapitalMember2022-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000320335us-gaap:RetainedEarningsMember2022-12-310000320335us-gaap:TreasuryStockCommonMember2022-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000320335us-gaap:RetainedEarningsMember2023-01-012023-03-310000320335us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000320335us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000320335us-gaap:PreferredStockMember2023-03-310000320335us-gaap:CommonStockMember2023-03-310000320335us-gaap:AdditionalPaidInCapitalMember2023-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000320335us-gaap:RetainedEarningsMember2023-03-310000320335us-gaap:TreasuryStockCommonMember2023-03-310000320335us-gaap:PreferredStockMember2021-12-310000320335us-gaap:CommonStockMember2021-12-310000320335us-gaap:AdditionalPaidInCapitalMember2021-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000320335us-gaap:RetainedEarningsMember2021-12-310000320335us-gaap:TreasuryStockCommonMember2021-12-3100003203352021-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000320335us-gaap:RetainedEarningsMember2022-01-012022-03-310000320335us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000320335us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000320335us-gaap:PreferredStockMember2022-03-310000320335us-gaap:CommonStockMember2022-03-310000320335us-gaap:AdditionalPaidInCapitalMember2022-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000320335us-gaap:RetainedEarningsMember2022-03-310000320335us-gaap:TreasuryStockCommonMember2022-03-3100003203352022-03-31gl:segmentxbrli:pure0000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMembersrt:ScenarioPreviouslyReportedMember2020-12-310000320335gl:LifeSegmentMembergl:DirectToConsumerMembersrt:ScenarioPreviouslyReportedMember2020-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMembersrt:ScenarioPreviouslyReportedMember2020-12-310000320335gl:LifeSegmentMembersrt:ScenarioPreviouslyReportedMembergl:OtherMember2020-12-310000320335gl:LifeSegmentMembersrt:ScenarioPreviouslyReportedMember2020-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2020-12-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2020-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2020-12-310000320335gl:LifeSegmentMembergl:OtherMember2020-12-310000320335gl:LifeSegmentMember2020-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2021-01-010000320335gl:DirectToConsumerMembergl:LifeSegmentMember2021-01-010000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2021-01-010000320335gl:LifeSegmentMembergl:OtherMember2021-01-010000320335gl:LifeSegmentMember2021-01-010000320335srt:ScenarioPreviouslyReportedMembergl:HealthSegmentMembergl:UnitedAmericanIndependentMember2020-12-310000320335gl:FamilyHeritageMembersrt:ScenarioPreviouslyReportedMembergl:HealthSegmentMember2020-12-310000320335gl:LibertyNationalExclusiveMembersrt:ScenarioPreviouslyReportedMembergl:HealthSegmentMember2020-12-310000320335gl:AmericanIncomeExclusiveMembersrt:ScenarioPreviouslyReportedMembergl:HealthSegmentMember2020-12-310000320335gl:DirectToConsumerMembersrt:ScenarioPreviouslyReportedMembergl:HealthSegmentMember2020-12-310000320335srt:ScenarioPreviouslyReportedMembergl:HealthSegmentMember2020-12-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2020-12-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2020-12-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2020-12-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2020-12-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2020-12-310000320335gl:HealthSegmentMember2020-12-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2021-01-010000320335gl:FamilyHeritageMembergl:HealthSegmentMember2021-01-010000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2021-01-010000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2021-01-010000320335gl:DirectToConsumerMembergl:HealthSegmentMember2021-01-010000320335gl:HealthSegmentMember2021-01-0100003203352021-01-0100003203352020-12-310000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2021-01-010000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2020-12-310000320335gl:AnnuitySegmentMember2021-01-010000320335gl:AnnuitySegmentMember2020-12-310000320335us-gaap:RetainedEarningsMember2020-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000320335gl:OtherShareholdersEquityMember2020-12-310000320335srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2020-12-310000320335srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000320335srt:CumulativeEffectPeriodOfAdoptionAdjustmentMembergl:OtherShareholdersEquityMember2020-12-310000320335srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-12-310000320335us-gaap:RetainedEarningsMember2021-01-010000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-010000320335gl:OtherShareholdersEquityMember2021-01-010000320335srt:ScenarioPreviouslyReportedMember2022-12-310000320335srt:RestatementAdjustmentMember2022-12-310000320335us-gaap:LifeInsuranceSegmentMembersrt:ScenarioPreviouslyReportedMember2022-01-012022-03-310000320335us-gaap:LifeInsuranceSegmentMembersrt:RestatementAdjustmentMember2022-01-012022-03-310000320335us-gaap:HealthInsuranceProductLineMembersrt:ScenarioPreviouslyReportedMember2022-01-012022-03-310000320335us-gaap:HealthInsuranceProductLineMembersrt:RestatementAdjustmentMember2022-01-012022-03-310000320335srt:ScenarioPreviouslyReportedMember2022-01-012022-03-310000320335srt:RestatementAdjustmentMember2022-01-012022-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000320335gl:FuturePolicyBenefitsMember2022-12-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310000320335gl:FuturePolicyBenefitsMember2023-01-012023-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310000320335gl:FuturePolicyBenefitsMember2023-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310000320335gl:FuturePolicyBenefitsMember2021-12-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310000320335gl:FuturePolicyBenefitsMember2022-01-012022-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-03-310000320335gl:FuturePolicyBenefitsMember2022-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:FinancialMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:EnergyMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FixedMaturitiesMember2023-03-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMembergl:BanksMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMembergl:BanksMemberus-gaap:FixedMaturitiesMember2022-12-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:FinancialMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:EnergyMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FixedMaturitiesMember2022-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:FixedMaturitiesMember2023-01-012023-03-310000320335us-gaap:FixedMaturitiesMember2022-01-012022-03-310000320335us-gaap:PolicyLoansMember2023-01-012023-03-310000320335us-gaap:PolicyLoansMember2022-01-012022-03-310000320335us-gaap:OtherLongTermInvestmentsMember2023-01-012023-03-310000320335us-gaap:OtherLongTermInvestmentsMember2022-01-012022-03-310000320335us-gaap:ShortTermInvestmentsMember2023-01-012023-03-310000320335us-gaap:ShortTermInvestmentsMember2022-01-012022-03-310000320335us-gaap:FairValueInputsLevel1Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:FairValueInputsLevel3Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000320335us-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMembergl:FinancialMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMembergl:FinancialMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMembergl:EnergyMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:EnergyMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMembergl:EnergyMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMemberus-gaap:CollateralizedDebtObligationsMember2023-03-310000320335us-gaap:FixedMaturitiesMemberus-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMemberus-gaap:CollateralizedDebtObligationsMember2023-03-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2023-03-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:FairValueInputsLevel3Membergl:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:FairValueInputsLevel1Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:FairValueInputsLevel3Membergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000320335us-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMembergl:FinancialMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMembergl:FinancialMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMembergl:EnergyMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:EnergyMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMembergl:EnergyMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMembergl:OtherCorporateSectorsMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMemberus-gaap:CollateralizedDebtObligationsMember2022-12-310000320335us-gaap:FixedMaturitiesMemberus-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMemberus-gaap:CollateralizedDebtObligationsMember2022-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2022-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:FairValueInputsLevel3Membergl:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:AssetBackedSecuritiesMember2022-12-310000320335us-gaap:CollateralizedDebtObligationsMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMember2022-12-310000320335us-gaap:AssetBackedSecuritiesMember2023-01-012023-03-310000320335us-gaap:CollateralizedDebtObligationsMember2023-01-012023-03-310000320335us-gaap:CorporateDebtSecuritiesMember2023-01-012023-03-310000320335us-gaap:AssetBackedSecuritiesMember2023-03-310000320335us-gaap:CollateralizedDebtObligationsMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMember2023-03-310000320335us-gaap:AssetBackedSecuritiesMember2021-12-310000320335us-gaap:CollateralizedDebtObligationsMember2021-12-310000320335us-gaap:CorporateDebtSecuritiesMember2021-12-310000320335us-gaap:AssetBackedSecuritiesMember2022-01-012022-03-310000320335us-gaap:CollateralizedDebtObligationsMember2022-01-012022-03-310000320335us-gaap:CorporateDebtSecuritiesMember2022-01-012022-03-310000320335us-gaap:AssetBackedSecuritiesMember2022-03-310000320335us-gaap:CollateralizedDebtObligationsMember2022-03-310000320335us-gaap:CorporateDebtSecuritiesMember2022-03-31gl:Issuegl:issuer0000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:FinancialMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:EnergyMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:OtherCorporateSectorsMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CollateralizedDebtObligationsMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMember2023-03-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:FinancialMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:UtilitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:EnergyMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:OtherCorporateSectorsMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2023-03-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CollateralizedDebtObligationsMember2023-03-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2023-03-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMember2023-03-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:FinancialMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:EnergyMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CorporateDebtSecuritiesMembergl:OtherCorporateSectorsMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMemberus-gaap:CollateralizedDebtObligationsMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2022-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMember2022-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:FinancialMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:UtilitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:EnergyMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:OtherCorporateSectorsMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2022-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:CollateralizedDebtObligationsMember2022-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMembergl:OtherAssetBackedSecuritiesMember2022-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2021-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-01-012023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2022-01-012022-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2022-03-310000320335us-gaap:ParticipatingMortgagesMember2023-03-310000320335us-gaap:ParticipatingMortgagesMember2022-12-310000320335us-gaap:OtherInvestmentsMember2023-03-310000320335us-gaap:OtherInvestmentsMember2022-12-310000320335srt:PartnershipInterestMemberus-gaap:CommercialMortgageBackedSecuritiesMember2023-03-310000320335srt:PartnershipInterestMemberus-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310000320335gl:OpportunisticCreditMembersrt:PartnershipInterestMember2023-03-310000320335gl:OpportunisticCreditMembersrt:PartnershipInterestMember2022-12-310000320335gl:OpportunisticCreditMembersrt:PartnershipInterestMember2023-01-012023-03-310000320335srt:PartnershipInterestMembergl:InfrastructureMember2023-03-310000320335srt:PartnershipInterestMembergl:InfrastructureMember2022-12-310000320335us-gaap:OtherInvestmentsMembersrt:PartnershipInterestMember2023-03-310000320335us-gaap:OtherInvestmentsMembersrt:PartnershipInterestMember2022-12-310000320335srt:PartnershipInterestMember2023-03-310000320335srt:PartnershipInterestMember2022-12-310000320335srt:PartnershipInterestMember2023-01-012023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:MixedUseMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:MixedUseMember2022-12-310000320335us-gaap:ParticipatingMortgagesMembergl:HospitalityMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:HospitalityMember2022-12-310000320335us-gaap:ParticipatingMortgagesMembergl:RetailPropertyMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:RetailPropertyMember2022-12-310000320335us-gaap:ParticipatingMortgagesMembersrt:IndustrialPropertyMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembersrt:IndustrialPropertyMember2022-12-310000320335us-gaap:ParticipatingMortgagesMembersrt:MultifamilyMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembersrt:MultifamilyMember2022-12-310000320335srt:OfficeBuildingMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335srt:OfficeBuildingMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335us-gaap:ParticipatingMortgagesMemberstpr:CA2023-03-310000320335us-gaap:ParticipatingMortgagesMemberstpr:CA2022-12-310000320335us-gaap:ParticipatingMortgagesMemberstpr:TX2023-03-310000320335us-gaap:ParticipatingMortgagesMemberstpr:TX2022-12-310000320335us-gaap:ParticipatingMortgagesMemberstpr:NY2023-03-310000320335us-gaap:ParticipatingMortgagesMemberstpr:NY2022-12-310000320335us-gaap:ParticipatingMortgagesMemberstpr:WA2023-03-310000320335us-gaap:ParticipatingMortgagesMemberstpr:WA2022-12-310000320335us-gaap:ParticipatingMortgagesMemberstpr:MA2023-03-310000320335us-gaap:ParticipatingMortgagesMemberstpr:MA2022-12-310000320335us-gaap:ParticipatingMortgagesMemberstpr:FL2023-03-310000320335us-gaap:ParticipatingMortgagesMemberstpr:FL2022-12-310000320335us-gaap:ParticipatingMortgagesMembergl:OtherGeographicalLocationMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:OtherGeographicalLocationMember2022-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2023-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMembergl:DebtServiceCoverageRatio1.00x1.20xMember2023-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMemberus-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMember2023-03-310000320335gl:LTV81PercentTo90PercentMembergl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:LTV81PercentTo90PercentMemberus-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2023-03-310000320335gl:LTV81PercentTo90PercentMembergl:DebtServiceCoverageRatioGreaterThan1.20xMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:LTV81PercentTo90PercentMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:LTVGreaterThan90PercentMembergl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:LTVGreaterThan90PercentMemberus-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2023-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVGreaterThan90PercentMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:LTVGreaterThan90PercentMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335us-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2023-03-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMemberus-gaap:ParticipatingMortgagesMember2023-03-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2022-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:LTVLessThan70PercentMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMember2022-12-310000320335us-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMembergl:DebtServiceCoverageRatio1.00x1.20xMember2022-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMemberus-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMember2022-12-310000320335us-gaap:ParticipatingMortgagesMembergl:LTV70PercentTo80PercentMember2022-12-310000320335gl:LTV81PercentTo90PercentMembergl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:LTV81PercentTo90PercentMemberus-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2022-12-310000320335gl:LTV81PercentTo90PercentMembergl:DebtServiceCoverageRatioGreaterThan1.20xMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:LTV81PercentTo90PercentMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:LTVGreaterThan90PercentMembergl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:LTVGreaterThan90PercentMemberus-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2022-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVGreaterThan90PercentMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:LTVGreaterThan90PercentMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMemberus-gaap:ParticipatingMortgagesMember2022-12-310000320335us-gaap:ParticipatingMortgagesMembergl:DebtServiceCoverageRatio1.00x1.20xMember2022-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMemberus-gaap:ParticipatingMortgagesMember2022-12-31gl:loan0000320335us-gaap:ParticipatingMortgagesMember2021-12-310000320335us-gaap:ParticipatingMortgagesMember2023-01-012023-03-310000320335us-gaap:ParticipatingMortgagesMember2022-01-012022-03-310000320335us-gaap:ParticipatingMortgagesMember2022-03-310000320335us-gaap:UnfundedLoanCommitmentMember2023-03-310000320335us-gaap:LetterOfCreditMember2023-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2021-12-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2021-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2021-12-310000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2021-12-310000320335gl:LifeSegmentMember2021-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2022-01-012022-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2022-01-012022-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2022-01-012022-03-310000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2022-01-012022-03-310000320335gl:LifeSegmentMember2022-01-012022-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2022-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2022-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2022-03-310000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2022-03-310000320335gl:LifeSegmentMember2022-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2022-12-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2022-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2022-12-310000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2022-12-310000320335gl:LifeSegmentMember2022-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2023-01-012023-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2023-01-012023-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2023-01-012023-03-310000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2023-01-012023-03-310000320335gl:LifeSegmentMember2023-01-012023-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2023-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2023-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2023-03-310000320335gl:LifeSegmentMemberus-gaap:OtherInsuranceProductLineMember2023-03-310000320335gl:LifeSegmentMember2023-03-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2021-12-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2021-12-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2021-12-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2021-12-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2021-12-310000320335gl:HealthSegmentMember2021-12-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2022-01-012022-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2022-01-012022-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2022-01-012022-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2022-01-012022-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2022-01-012022-03-310000320335gl:HealthSegmentMember2022-01-012022-03-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2022-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2022-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2022-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2022-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2022-03-310000320335gl:HealthSegmentMember2022-03-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2022-12-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2022-12-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2022-12-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2022-12-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2022-12-310000320335gl:HealthSegmentMember2022-12-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2023-01-012023-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2023-01-012023-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2023-01-012023-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2023-01-012023-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2023-01-012023-03-310000320335gl:HealthSegmentMember2023-01-012023-03-310000320335gl:HealthSegmentMembergl:UnitedAmericanIndependentMember2023-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2023-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2023-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2023-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2023-03-310000320335gl:HealthSegmentMember2023-03-310000320335us-gaap:MeasurementInputMortalityRateMembergl:HealthSegmentMember2023-03-310000320335gl:HealthSegmentMemberus-gaap:MeasurementInputMorbidityRateMember2023-03-310000320335us-gaap:MeasurementInputMortalityRateMembergl:HealthSegmentMember2022-03-310000320335gl:HealthSegmentMemberus-gaap:MeasurementInputMorbidityRateMember2022-03-310000320335us-gaap:InterestSensitiveLifeMember2022-12-310000320335us-gaap:DeferredFixedAnnuityMember2022-12-310000320335us-gaap:OtherInsuranceProductLineMember2022-12-310000320335us-gaap:InterestSensitiveLifeMember2021-12-310000320335us-gaap:DeferredFixedAnnuityMember2021-12-310000320335us-gaap:OtherInsuranceProductLineMember2021-12-310000320335us-gaap:InterestSensitiveLifeMember2023-01-012023-03-310000320335us-gaap:DeferredFixedAnnuityMember2023-01-012023-03-310000320335us-gaap:InterestSensitiveLifeMember2022-01-012022-03-310000320335us-gaap:DeferredFixedAnnuityMember2022-01-012022-03-310000320335us-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:DeferredFixedAnnuityMember2023-03-310000320335us-gaap:OtherInsuranceProductLineMember2023-03-310000320335us-gaap:InterestSensitiveLifeMember2022-03-310000320335us-gaap:DeferredFixedAnnuityMember2022-03-310000320335us-gaap:OtherInsuranceProductLineMember2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:OtherInsuranceProductLineMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMemberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMemberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:OtherInsuranceProductLineMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembersrt:MinimumMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembersrt:MaximumMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:OtherInsuranceProductLineMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:OtherInsuranceProductLineMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:InterestSensitiveLifeMember2023-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:OtherInsuranceProductLineMember2023-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:InterestSensitiveLifeMember2022-12-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:InterestSensitiveLifeMember2022-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Memberus-gaap:OtherInsuranceProductLineMember2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMemberus-gaap:InterestSensitiveLifeMember2022-12-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMemberus-gaap:InterestSensitiveLifeMember2022-12-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:InterestSensitiveLifeMember2022-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Memberus-gaap:OtherInsuranceProductLineMember2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembersrt:MinimumMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2022-12-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembersrt:MaximumMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2022-12-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Memberus-gaap:InterestSensitiveLifeMember2022-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:OtherInsuranceProductLineMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:InterestSensitiveLifeMember2022-12-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:InterestSensitiveLifeMember2022-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMemberus-gaap:OtherInsuranceProductLineMember2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:InterestSensitiveLifeMember2022-03-310000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2022-03-310000320335us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:OtherInsuranceProductLineMember2022-03-310000320335gl:AnnuitySegmentMember2023-03-310000320335gl:AnnuitySegmentMember2022-03-310000320335us-gaap:HealthInsuranceProductLineMember2022-12-310000320335us-gaap:HealthInsuranceProductLineMember2021-12-310000320335us-gaap:HealthInsuranceProductLineMember2022-01-012022-12-310000320335us-gaap:HealthInsuranceProductLineMember2023-03-310000320335us-gaap:LifeInsuranceSegmentMember2023-03-310000320335us-gaap:LifeInsuranceSegmentMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:CorporateBondSecuritiesEnergyMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesEnergyMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:CorporateBondSecuritiesEnergyMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesEnergyMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:CorporateBondSecuritiesOtherMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesOtherMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:CorporateBondSecuritiesOtherMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesOtherMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2023-03-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:GuaranteedAnnuityContractMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:GuaranteedAnnuityContractMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2023-03-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:OtherMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:OtherMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMember2023-12-310000320335us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesFinancialMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesUtilitiesMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:CorporateBondSecuritiesEnergyMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesEnergyMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:CorporateBondSecuritiesEnergyMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesEnergyMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:CorporateBondSecuritiesOtherMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesOtherMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:CorporateBondSecuritiesOtherMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:CorporateBondSecuritiesOtherMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateBondSecuritiesMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2022-12-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:GuaranteedAnnuityContractMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:GuaranteedAnnuityContractMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2022-12-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Membergl:OtherMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Membergl:OtherMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMember2022-12-310000320335us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:QualifiedPlanMemberus-gaap:FundedPlanMember2023-03-310000320335us-gaap:PensionPlansDefinedBenefitMemberus-gaap:QualifiedPlanMemberus-gaap:FundedPlanMember2022-12-310000320335us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:NonqualifiedPlanMember2023-03-310000320335us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:NonqualifiedPlanMember2022-12-310000320335gl:NotesDueMayFifteenTwoThousandTwentyThreeMember2023-03-310000320335gl:NotesDueMayFifteenTwoThousandTwentyThreeMember2022-12-310000320335gl:SeniorNotesDueSeptember152028Member2023-03-310000320335gl:SeniorNotesDueSeptember152028Member2022-12-310000320335gl:SeniorNotesDueAugust152030Member2023-03-310000320335gl:SeniorNotesDueAugust152030Member2022-12-310000320335gl:SeniorNotesDueJune152032Member2023-03-310000320335gl:SeniorNotesDueJune152032Member2022-12-310000320335gl:JuniorSubordinatedDebenturesDue2057Member2023-03-310000320335gl:JuniorSubordinatedDebenturesDue2057Member2022-12-310000320335gl:JuniorSubordinatedDebenturesDue2061Member2023-03-310000320335gl:JuniorSubordinatedDebenturesDue2061Member2022-12-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2023-03-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2022-12-310000320335us-gaap:CommercialPaperMember2023-03-310000320335us-gaap:CommercialPaperMember2022-12-310000320335srt:SubsidiariesMembergl:SeniorNotesDueJune152032Membersrt:ConsolidationEliminationsMember2023-03-310000320335us-gaap:SeniorNotesMember2023-01-012023-03-310000320335gl:JuniorSubordinatedDebenturesDue2056Member2023-03-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2023-03-310000320335us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetPledgedAsCollateralMember2023-03-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2022-12-310000320335gl:AmericanIncomeExclusiveMembergl:AnnuitySegmentMember2023-01-012023-03-310000320335gl:AmericanIncomeExclusiveMember2023-01-012023-03-310000320335gl:DirectResponseMembergl:LifeSegmentMember2023-01-012023-03-310000320335gl:DirectResponseMembergl:HealthSegmentMember2023-01-012023-03-310000320335gl:DirectResponseMembergl:AnnuitySegmentMember2023-01-012023-03-310000320335gl:DirectResponseMember2023-01-012023-03-310000320335gl:LibertyNationalExclusiveMembergl:AnnuitySegmentMember2023-01-012023-03-310000320335gl:LibertyNationalExclusiveMember2023-01-012023-03-310000320335gl:LifeSegmentMembergl:UnitedAmericanIndependentMember2023-01-012023-03-310000320335gl:AnnuitySegmentMembergl:UnitedAmericanIndependentMember2023-01-012023-03-310000320335gl:UnitedAmericanIndependentMember2023-01-012023-03-310000320335gl:FamilyHeritageMembergl:LifeSegmentMember2023-01-012023-03-310000320335gl:FamilyHeritageMembergl:AnnuitySegmentMember2023-01-012023-03-310000320335gl:FamilyHeritageMember2023-01-012023-03-310000320335gl:LifeSegmentMembergl:DistributionChannelOtherMember2023-01-012023-03-310000320335gl:HealthSegmentMembergl:DistributionChannelOtherMember2023-01-012023-03-310000320335gl:AnnuitySegmentMembergl:DistributionChannelOtherMember2023-01-012023-03-310000320335gl:DistributionChannelOtherMember2023-01-012023-03-310000320335gl:AnnuitySegmentMember2023-01-012023-03-310000320335gl:AmericanIncomeExclusiveMembergl:AnnuitySegmentMember2022-01-012022-03-310000320335gl:AmericanIncomeExclusiveMember2022-01-012022-03-310000320335gl:DirectResponseMembergl:LifeSegmentMember2022-01-012022-03-310000320335gl:DirectResponseMembergl:HealthSegmentMember2022-01-012022-03-310000320335gl:DirectResponseMembergl:AnnuitySegmentMember2022-01-012022-03-310000320335gl:DirectResponseMember2022-01-012022-03-310000320335gl:LibertyNationalExclusiveMembergl:AnnuitySegmentMember2022-01-012022-03-310000320335gl:LibertyNationalExclusiveMember2022-01-012022-03-310000320335gl:LifeSegmentMembergl:UnitedAmericanIndependentMember2022-01-012022-03-310000320335gl:AnnuitySegmentMembergl:UnitedAmericanIndependentMember2022-01-012022-03-310000320335gl:UnitedAmericanIndependentMember2022-01-012022-03-310000320335gl:FamilyHeritageMembergl:LifeSegmentMember2022-01-012022-03-310000320335gl:FamilyHeritageMembergl:AnnuitySegmentMember2022-01-012022-03-310000320335gl:FamilyHeritageMember2022-01-012022-03-310000320335gl:LifeSegmentMembergl:DistributionChannelOtherMember2022-01-012022-03-310000320335gl:HealthSegmentMembergl:DistributionChannelOtherMember2022-01-012022-03-310000320335gl:AnnuitySegmentMembergl:DistributionChannelOtherMember2022-01-012022-03-310000320335gl:DistributionChannelOtherMember2022-01-012022-03-310000320335gl:AnnuitySegmentMember2022-01-012022-03-310000320335gl:LifeSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000320335gl:HealthSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000320335gl:AnnuitySegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000320335us-gaap:OperatingSegmentsMembergl:InvestmentSegmentMember2023-01-012023-03-310000320335us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000320335us-gaap:MaterialReconcilingItemsMember2023-01-012023-03-310000320335us-gaap:OperatingSegmentsMember2023-01-012023-03-310000320335gl:LifeSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000320335gl:HealthSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000320335gl:AnnuitySegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000320335us-gaap:OperatingSegmentsMembergl:InvestmentSegmentMember2022-01-012022-03-310000320335us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000320335us-gaap:MaterialReconcilingItemsMember2022-01-012022-03-310000320335us-gaap:OperatingSegmentsMember2022-01-012022-03-310000320335gl:NotesDueMayFifteenTwoThousandTwentyThreeMemberus-gaap:SubsequentEventMember2023-05-090000320335gl:FirstRepublicBankMember2023-03-310000320335gl:FirstRepublicBankMemberus-gaap:SubsequentEventMember2023-05-09
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark one)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ________
Commission File Number: 001-08052
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware   63-0780404
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
3700 South Stonebridge Drive, McKinney, Texas 75070
(Address of principal executive offices) (Zip Code)

(972) 569-4000
(Registrant’s telephone number, including area code)

NONE
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value per share GL New York Stock Exchange
4.250% Junior Subordinated Debentures GL PRD New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                 Yes    ☒   No   ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).                                             Yes   ☒   No   ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes   ☐   No   ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class   Outstanding at April 28, 2023
Common Stock, $1.00 Par Value   95,554,844
GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Table of Contents
Page
PART I. FINANCIAL INFORMATION
Item 1.
Item 2.
Item 3.
Item 4.
PART II. OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 6.





As used in this Form 10-Q, “Globe Life,” the “Company,” “we,” “our” and “us” refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
GL Q1 2023 FORM 10-Q
Table of Contents
PART I—FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements

Globe Life Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(Dollar amounts in thousands, except per share data)
March 31,
2023		 December 31, 2022
Assets:
Investments:
Fixed maturities—available for sale, at fair value (amortized cost: 2023—$18,526,703;
2022—$18,301,692, allowance for credit losses: 2023— $32,767; 2022— $0)
 $ 17,206,885  $ 16,503,365 
Policy loans 622,736  614,866 
Other long-term investments (includes: 2023—$789,197; 2022—$768,689 under the fair value option)
 1,022,611  976,016 
Short-term investments 74,377  114,121 
Total investments 18,926,609  18,208,368 
Cash 172,108  92,559 
Accrued investment income 279,445  259,581 
Other receivables 594,421  589,079 
Deferred acquisition costs 5,654,438  5,535,697 
Goodwill 481,791  481,791 
Other assets 751,311  760,066 
Total assets $ 26,860,123  $ 25,927,141 
Liabilities:
Future policy benefits at current discount rates: (at original rates: 2023—$16,442,516; 2022—$16,306,870)
 $ 18,896,574  $ 18,040,042 
Unearned and advance premium 271,517  253,140 
Policy claims and other benefits payable 489,296  507,219 
Other policyholders' funds 142,686  123,236 
Total policy liabilities 19,800,073  18,923,637 
Current and deferred income taxes 427,608  434,649 
Short-term debt 514,247  449,103 
Long-term debt (estimated fair value: 2023—$1,484,172; 2022—$1,440,277)
 1,628,354  1,627,952 
Other liabilities 643,550  542,223 
Total liabilities 23,013,832  21,977,564 
Commitments and Contingencies (Note 5)
Shareholders' equity:
Preferred stock, par value $1 per share—5,000,000 shares authorized; outstanding: 0 in 2023 and 2022
 —  — 
Common stock, par value $1 per share—320,000,000 shares authorized; outstanding: (2023—105,218,183 issued; 2022—105,218,183 issued)
 105,218  105,218 
Additional paid-in-capital 528,639  529,661 
Accumulated other comprehensive income (loss) (2,961,093) (2,790,313)
Retained earnings 7,092,544  6,894,535 
Treasury stock, at cost: (2023—9,489,745 shares; 2022—8,478,288 shares)
 (919,017) (789,524)
Total shareholders' equity 3,846,291  3,949,577 
Total liabilities and shareholders' equity $ 26,860,123  $ 25,927,141 
Prior period amounts have been adjusted for the adoption of ASU 2018-12 on January 1, 2023.
See accompanying Notes to Condensed Consolidated Financial Statements.
1
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(Dollar amounts in thousands, except per share data)
Three Months Ended
March 31,
2023 2022
Revenue:
Life premium $ 772,597  $ 749,128 
Health premium 322,493  315,684 
Other premium —  — 
Total premium 1,095,090  1,064,812 
Net investment income 257,105  244,894 
Realized gains (losses) (30,927) (7,244)
Other income 50  164 
Total revenue 1,321,318  1,302,626 
Benefits and expenses:
Life policyholder benefits (net of remeasurement (gain) loss: 2023—$(2,697); 2022—$5,783)
 507,977  495,429 
Health policyholder benefits (net of remeasurement (gain) loss: 2023—$2,038; 2022—$(1,959))
 190,962  189,018 
Other policyholder benefits 8,988  9,702 
Total policyholder benefits 707,927  694,149 
Amortization of deferred acquisition costs 92,322  84,496 
Commissions, premium taxes, and non-deferred acquisition costs 137,797  125,509 
Other operating expense 84,171  84,352 
Interest expense 24,867  19,944 
Total benefits and expenses 1,047,084  1,008,450 
Income before income taxes 274,234  294,176 
Income tax benefit (expense) (50,624) (56,692)
Net income
$ 223,610  $ 237,484 
Basic net income per common share
$ 2.32  $ 2.39 
Diluted net income per common share
$ 2.28  $ 2.37 












Prior period amounts have been adjusted for the adoption of ASU 2018-12 on January 1, 2023.
See accompanying Notes to Condensed Consolidated Financial Statements.
2
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)
(Dollar amounts in thousands)
Three Months Ended
March 31,
2023 2022
Net income
$ 223,610  $ 237,484 
Other comprehensive income (loss):
Investments:
Unrealized gains (losses) on fixed maturities:
Unrealized holding gains (losses) arising during period 469,119  (2,292,922)
Other reclassification adjustments included in net income 32,590  (4,030)
Foreign exchange adjustment on fixed maturities recorded at fair value 9,567  284 
Total unrealized investment gains (losses) 511,276  (2,296,668)
Less applicable tax (expense) benefit (107,368) 482,299 
Unrealized gains (losses) on investments, net of tax 403,908  (1,814,369)
Future Policy Benefits:
Change in discount rate on future policy benefits (720,890) 2,805,511 
Less applicable tax (expense) benefit 151,387  (589,156)
Future policy benefit adjustments, net of tax (569,503) 2,216,355 
Foreign exchange translation:
Foreign exchange translation adjustments, other than securities (6,516) 4,228 
Less applicable tax (expense) benefit 1,368  (887)
Foreign exchange translation adjustments, other than securities, net of tax (5,148) 3,341 
Pension:
Pension adjustments (48) 3,437 
Less applicable tax (expense) benefit 11  (722)
Pension adjustments, net of tax (37) 2,715 
Other comprehensive income (loss) (170,780) 408,042 
Comprehensive income (loss)
$ 52,830  $ 645,526 










Prior period amounts have been adjusted for the adoption of ASU 2018-12 on January 1, 2023.
See accompanying Notes to Condensed Consolidated Financial Statements.

3
        GL Q1 2023 FORM 10-Q
Table of Contents

Globe Life Inc.
Condensed Consolidated Statements of Shareholders' Equity
(Unaudited)
(Dollar amounts in thousands, except per share data)


Preferred Stock Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Retained Earnings Treasury Stock Total Shareholders' Equity
Balance at December 31, 2022
$ —  $ 105,218  $ 529,661  $ (2,790,313) $ 6,894,535  $ (789,524) $ 3,949,577 
Comprehensive income (loss) —  —  —  (170,780) 223,610  —  52,830 
Common dividends declared
($0.2250 per share)
 —  —  —  —  (21,542) —  (21,542)
Acquisition of treasury stock —  —  —  —  —  (179,276) (179,276)
Stock-based compensation —  —  (1,022) —  —  8,700  7,678 
Exercise of stock options —  —  —  —  (4,059) 41,083  37,024 
Balance at March 31, 2023
$ —  $ 105,218  $ 528,639  $ (2,961,093) $ 7,092,544  $ (919,017) $ 3,846,291 






Preferred Stock Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Retained Earnings Treasury Stock Total Shareholders' Equity
Balance at December 31, 2021
$ —  $ 109,218  $ 520,564  $ (4,235,048) $ 6,455,733  $ (846,659) $ 2,003,808 
Comprehensive income (loss) —  —  —  408,042  237,484  —  645,526 
Common dividends declared
($0.2075 per share)
 —  —  —  —  (20,543) —  (20,543)
Acquisition of treasury stock —  —  —  —  —  (119,482) (119,482)
Stock-based compensation —  —  2,504  —  (345) 6,876  9,035 
Exercise of stock options —  —  —  —  (9,964) 35,895  25,931 
Balance at March 31, 2022
$ —  $ 109,218  $ 523,068  $ (3,827,006) $ 6,662,365  $ (923,370) $ 2,544,275 
.

















Prior period amounts have been adjusted for the adoption of ASU 2018-12 on January 1, 2023.
See accompanying Notes to Condensed Consolidated Financial Statements.
4
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(Dollar amounts in thousands)
Three Months Ended
March 31,
2023 2022
Cash provided from (used for) operating activities
$ 477,330  $ 397,133 
Cash provided from (used for) investing activities:
Investments sold or matured:
Fixed maturities available for sale—sold 15,705  75,116 
Fixed maturities available for sale—matured or other redemptions 61,560  115,160 
Other long-term investments 1,950  20,929 
Total investments sold or matured 79,215  211,205 
Acquisition of investments:
Fixed maturities—available for sale (285,505) (339,145)
Other long-term investments (47,898) (122,010)
Total investments acquired (333,403) (461,155)
Net (increase) decrease in policy loans (7,870) (2,324)
Net (increase) decrease in short-term investments 39,744  11,801 
Additions to property and equipment (8,210) (6,981)
Investments in low-income housing interests (17,246) (27,870)
Cash provided from (used for) investing activities
(247,770) (275,324)
Cash provided from (used for) financing activities:
Issuance of common stock 37,024  25,931 
Cash dividends paid to shareholders (20,071) (19,687)
Short-term borrowings from FHLB 45,000  — 
Net borrowing (repayment) of commercial paper 20,070  42,348 
Acquisition of treasury stock (179,276) (119,482)
Net receipts (payments) from deposit-type products (54,487) (13,810)
Cash provided from (used for) financing activities
(151,740) (84,700)
Effect of foreign exchange rate changes on cash 1,729  (1,644)
Net increase (decrease) in cash 79,549  35,465 
Cash at beginning of year 92,559  92,163 
Cash at end of period $ 172,108  $ 127,628 










Prior period amounts have been adjusted for the adoption of ASU 2018-12 on January 1, 2023.
See accompanying Notes to Condensed Consolidated Financial Statements.
5
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

Note 1—Significant Accounting Policies

Business: (Globe Life), (the Company), refers to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and Globe Life Inc. subsidiaries and affiliates. Globe Life Inc.'s direct or indirect primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The underwriting companies are owned by their ultimate corporate parent, Globe Life Inc. (Parent Company).

Globe Life provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The Company is organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments.

Globe Life markets its insurance products through a number of distribution channels, each of which sells the products of one or more of Globe Life's insurance segments. Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (DTC).

Basis of Presentation: The accompanying condensed consolidated financial statements of Globe Life have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all of the disclosures required by accounting principles generally accepted in the United States of America (GAAP) for annual financial statements. However, in the opinion of management, these statements include all adjustments, consisting of normal recurring adjustments, which are necessary for a fair presentation of the condensed consolidated financial position at March 31, 2023, and the condensed consolidated results of operations, comprehensive income, and cash flows for the periods ended March 31, 2023 and 2022. The interim period condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements that are included in the Form 10-K filed with the Securities Exchange Commission (SEC) on February 23, 2023.

Use of Estimates: The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes.

Significant Accounting Policy Updates: The following accounting policies were updated since the 2022 Form 10-K due to the adoption of ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (ASU 2018-12). Refer to Note 2—New Accounting Standards for additional information on the financial statement impacts related to the adoption of this standard.

Future Policy Benefits—The liability for future policy benefits for traditional and limited-payment long duration life and health products comprises approximately 91% of the total liability for future policy benefits. The liability is determined each reporting period based on the net level premium method. This method requires the liability for future policy benefits be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders. Net level premiums reflect a recomputed net premium ratio1 using actual experience since the issue date or the Transition Date, and expected future experience. The liability is accrued as premium revenue is recognized and adjusted for differences between actual and expected experience. Long-duration insurance contracts issued by the Company are grouped into cohorts based on the contract issue year, distribution channel, legal entity and product type.
1 The net premium ratio is the percentage of gross premiums needed to fund actual and expected benefits and related settlement expenses.
6
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Both the present value of expected future benefit payments and the present value of expected future net premiums are based primarily on assumptions of discount rates, mortality, morbidity, lapse, and persistency. Each quarter, the Company remeasures its liability for future policy benefits using current discount rates with the effect of the change recognized in Other Comprehensive Income, a component of shareholders’ equity. In addition, the Company recognizes a liability remeasurement gain or loss within the Condensed Consolidated Statements of Operations using original discount rates, and relating to actual experience under the net premium calculation, as compared to the prior reporting period assumptions.

The Company reviews, and updates as necessary, its cash flow assumptions (mortality, morbidity, lapses and persistency) used to calculate the change in the liability for future policy benefits at least annually. These cash flow assumptions are reviewed at the same time every year, or more frequently, if suggested by experience. If cash flow assumptions are changed, the net premium ratio is recalculated from the original issue date, or the Transition Date, using actual experience and projected future cash flows. When the expected future net premiums exceed the expected future gross premiums, or the present value of future policyholder benefits exceeds the present value of expected future gross premiums, the liability for future policy benefits is adjusted with changes recognized in policyholder benefits on the Condensed Consolidated Statements of Operations. The cash flow assumptions do not include an adjustment for adverse deviation. Mortality tables used for individual life insurance include various industry tables and reflect modifications based on Company experience. Morbidity assumptions for individual health are based on Company experience and industry data. Lapse and persistency assumptions are based on Globe Life's experience.

The liability for future policy benefits is discounted as noted above, using a current upper-medium grade fixed-income instrument yield that reflects the duration characteristics of the liability for future policy benefits. The methodology for determining current discount rates consists of constructing a discount rate curve intended to be reflective of the currency and tenor of the insurance liability cash flows. The methodology is designed to prioritize observable inputs based on market data available in the local debt markets denominated in the same currency as the policies. For the discount rates applicable to tenors for which the single-A debt market is not liquid or there is little or no observable market data, the Company will use estimation techniques consistent with the fair value guidance in ASC 820. We further accrete interest as a component of policyholder benefits using the original discount rate that is locked-in during the year of contract issuance. The original discount rates (or the locked-in discount rates) are used for interest accretion purposes and for the determination of net premiums, whereas the current discount rates are used for purposes of valuing the liability.

The liability for future policy benefits for annuity and interest sensitive life-type products is represented by policy account value. For limited-payment contracts, a deferred profit liability is also recorded, with changes recognized in income over the life of the contract in proportion to the amount of insurance in force.

Deferred Acquisition Costs—Certain costs of acquiring new insurance business are deferred and recorded as an asset. These costs are capitalized on a grouped contract basis and amortized over the expected term of the related contracts, and are essential for the acquisition of new insurance business. Deferred acquisition costs (DAC) are directly related to the successful issuance of an insurance contract, and primarily include sales commissions, policy issue costs, direct to consumer advertising costs, and underwriting costs. Additionally, DAC includes the value of business acquired (VOBA), which are the costs of acquiring blocks of insurance from other companies or through the acquisition of other companies. These costs represent the difference between the fair value of the contractual insurance assets acquired and liabilities assumed, compared against the assets and liabilities for insurance contracts that the Company issues or holds measured in accordance with GAAP.

DAC is amortized on a constant-level basis over the expected term of the grouped contracts, with the related expense included in amortization of deferred acquisition costs on the Condensed Consolidated Statements of Operations. The in-force metric used to compute the DAC amortization rate is annualized premium in force. The assumptions used to amortize acquisition costs include mortality, morbidity, and persistency. These assumptions are reviewed at least annually and revised in conjunction with any change in the future policy benefit assumptions. The effect of changes in the assumptions are recognized over the remaining expected contract term as a revision of future amortization amounts.
7
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
VOBA is amortized on a basis that is consistent with DAC, as described above, and is subject to periodic recoverability and loss recognition testing to determine if there is a premium deficiency. These tests evaluate whether the present value of future contract-related cash flows will support the capitalized VOBA asset. These cash flows consist primarily of premium income, less benefits and expenses. The present value of these cash flows, less the reserve liability, is then compared with the unamortized balance. In the event the estimated present value of net cash flows is less, the deficiency would be recognized by a charge to earnings and either a reduction of unamortized acquisition costs or an increase in the liability for future benefits.


Note 2—New Accounting Standards

Accounting Pronouncements Adopted in the Current Year: On January 1, 2023, the Company adopted ASU 2018-12 on a modified retrospective basis as of the transition date (Transition Date) of January 1, 2021. The amended guidance is a significant change to the accounting and disclosure of long-duration life and health insurance contracts. The modified retrospective transition method requires the updated standard be applied to all long-duration life and health contracts, which has resulted in the adjustment of the 2021 and 2022 consolidated financial statements.

The following tables summarize the balance of and changes to the liability for future policy benefits for traditional life and health long-duration contracts on the Transition Date due to the adoption of ASU 2018-12:
Net Liability for Future Policy Benefits - Long Duration Life
American Income DTC Liberty National Other Total
Balance, net of reinsurance, at original discount rates as of December 31, 2020
$ 3,541,317  $ 2,492,226  $ 2,140,071  $ 2,736,804  $ 10,910,418 
Effect of changes in discount rate assumptions 3,334,600  2,195,430  1,229,610  2,297,835  9,057,475 
Effect of capping and flooring(1)
 —  16,899  2,433  2  19,334 
Balance, net of reinsurance, at current discount rates as of January 1, 2021
$ 6,875,917  $ 4,704,555  $ 3,372,114  $ 5,034,641  $ 19,987,227 

Net liability for Future Policy Benefits - Long Duration Health
United American Family Heritage Liberty National American Income DTC Total
Balance, net of reinsurance, at original discount rates as of December 31, 2020
$ 131,505  $ 1,383,128  $ 501,312  $ 101,998  $ (2,941) $ 2,115,002 
Effect of changes in discount rate assumptions 75,652  497,250  219,992  60,366  346  853,606 
Effect of capping and flooring(1)
 6,506  —  19,324  —  4,193  30,023 
Balance, net of reinsurance, at current discount rates as of January 1, 2021
$ 213,663  $ 1,880,378  $ 740,628  $ 162,364  $ 1,598  $ 2,998,631 
(1)When the present value of expected future net premiums exceeds the present value of expected future gross premiums for a given cohort (capping), or the present value of future policy benefits and related termination expenses exceeds the present value of expected future net premiums (flooring), an adjustment is made to the liability for future policy benefits.
8
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents total policy liabilities, both before and after the Transition Date:
January 1, December 31,
2021 2020
Future policy benefits:
Net liability for future policy benefits—long duration life $ 19,987,227  $ 10,910,418 
Net liability for future policy benefits—long duration health 2,998,631  2,115,002 
Additional insurance liabilities(1),(2)
 2,008,399  2,218,116 
Total future policy benefits 24,994,257  15,243,536 
Unearned and advance premium(1)
 243,369  61,728 
Policy claims and other benefits payable(1)
 473,524  399,507 
Other policyholders' funds(1)
 98,459  97,968 
Total policy liabilities
$ 25,809,609  $ 15,802,739 
(1)In addition to the discount rate related adjustments to future policy benefits, the Company reclassified certain balances within total policy liabilities on the Consolidated Balance Sheets as a result of adopting ASU 2018-12. The reclassifications had an immaterial impact on Shareholders' Equity. See table summarizing the transition adjustments to Shareholders' Equity below.
(2)The Company's additional insurance liabilities consist primarily of: 1) deferred profit liability on limited-payment contracts; and 2) reserves on deferred annuity and interest sensitive life blocks of business. See Note 6—Policy Liabilities for additional information.


The following table presents the Company's deferred policy acquisition costs, both before and after the Transition Date:
January 1, December 31,
2021 2020
Life:
American Income $ 1,647,761  $ 1,647,761 
Direct to Consumer 1,498,970  1,498,435 
Liberty National 531,504  531,504 
Other 304,786  304,459 
Total life 3,983,021  3,982,159 
Health:
United American 65,020  74,353 
Family Heritage 364,751  364,751 
Liberty National 124,754  124,888 
American Income 39,477  39,477 
Direct to Consumer 2,215  6,600 
Total health 596,217  610,069 
Annuity 8,309  3,216 
Total DAC
$ 4,587,547  $ 4,595,444 

In accordance with ASU 2018-12, the Company has adjusted its DAC balance to remove the impact of unrealized gains and losses that were previously recorded in Accumulated Other Comprehensive Income (AOCI) on the Consolidated Statements of Shareholders' Equity. Under prior guidance, the Company included these amounts within its calculation of amortization.


9
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents the effect of transition adjustments due to the adoption of ASU 2018-12 on Shareholders' Equity:
Retained Earnings Accumulated Other Comprehensive Income (Loss)
Other(1)
 Total
Shareholders’ Equity, as of December 31, 2020
$ 5,874,109  $ 3,029,244  $ (132,261) $ 8,771,092 
Effect of changes in discount rate assumptions —  (7,829,753) —  (7,829,753)
Effect of capping and flooring (38,992) —  —  (38,992)
Effect of removal of unrealized gain (loss) on DAC —  4,704  —  4,704 
Other adjustments 26,470  —  —  26,470 
Shareholders’ Equity, as of January 1, 2021
$ 5,861,587  $ (4,795,805) $ (132,261) $ 933,521 
(1)Other represents common stock, additional paid-in capital, and treasury stock, combining balances that were unaffected by the new standard.

As of the Transition Date, the primary effects of the changes required by the standard were to AOCI and retained earnings. As seen in the table above, the transition adjustments impacting AOCI consist of the effect of changes in discount rate assumptions and the effect of the removal of unrealized gains (losses) on DAC. The effect of changes in discount rate assumptions is the impact, net of tax, of the Company re-measuring its liability for future policy benefits using current discount rates. As of the Transition Date, we experienced a lower level of current discount rates than the original discount rates used in valuing our future policy benefits under the prior guidance, thus reducing Shareholders' Equity. For the effect of removing unrealized gains (losses) on DAC, this adjustment relates to the requirement to remove unrealized gains (losses) that were included within the amortization calculation, as noted previously.

Regarding the impact on retained earnings, when the present value of net premiums exceeds the present value of gross premiums for a given cohort (capping), or the present value of future benefits and related termination expenses exceeds the present value of future gross premiums (flooring), an adjustment is recognized to the liability for future policy benefits. Any blocks of business that require increases in future policy benefits to minimum levels, or that have a net premium ratio greater than 100%, required an adjustment to the opening balance of retained earnings (decrease).

Accounting Pronouncements Yet to be Adopted: ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, adds disclosure requirements specific to equity securities subject to contractual sale restrictions. The disclosures clarify the nature of the contractual sale as well as the duration of the restriction and the circumstances that could cause a lapse in the restriction.

This standard is effective for the Company on January 1, 2024, and will be implemented on a prospective basis. The Company does not expect the standard will have a material impact on the Consolidated Financial Statements.


10
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Effect of New Accounting Standards on Previously Reported Results: The impacts from the adoption of ASU 2018-12 on the Company's previously reported results included in these financial statements are as follows:

Condensed Consolidated Balance Sheets
December 31, 2022
As Previously Reported Adoption Impact As Adjusted
Assets:
Other receivables $ 484,887  $ 104,192  $ 589,079 
Deferred acquisition costs 5,249,907  285,790  5,535,697 
Liabilities:
Future policy benefits 16,721,846  1,318,196  18,040,042 
Unearned and advance premium 60,742  192,398  253,140 
Policy claims and other benefits payable 430,027  77,192  507,219 
Current and deferred income taxes 686,172  (251,523) 434,649 
Shareholders' equity:
Accumulated other comprehensive income (loss) (1,415,714) (1,374,599) (2,790,313)
Retained earnings 6,466,220  428,315  6,894,535 

Condensed Consolidated Statements of Operations
Three Months Ended
March 31, 2022
As Previously Reported Adoption Impact As Adjusted
Revenue:
Life premium $ 754,602  $ (5,474) $ 749,128 
Health premium 317,000  (1,316) 315,684 
Net investment income 243,834  1,060  244,894 
Benefits and expenses:
Life policyholder benefits 549,343  (53,914) 495,429 
Health policyholder benefits 196,855  (7,837) 189,018 
Other policyholder benefits 7,050  2,652  9,702 
Amortization of deferred acquisition costs 158,384  (73,888) 84,496 
Commissions, premium taxes, and non-deferred acquisition costs 90,813  34,696  125,509 
Income before income taxes 201,615  92,561  294,176 
Income tax benefit (expense) (37,254) (19,438) (56,692)
Net income
$ 164,361  $ 73,123  $ 237,484 
Basic net income per common share
$ 1.66  $ 0.73  $ 2.39 
Diluted net income per common share
$ 1.64  $ 0.73  $ 2.37 

See Note 1—Significant Accounting Policies, Note 6—Policy Liabilities, and Note 7—DAC for additional information on the adoption.

11
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 3—Supplemental Information about Changes to Accumulated Other Comprehensive Income

Components of Accumulated Other Comprehensive Income: An analysis of the change in balance by component of Accumulated Other Comprehensive Income is as follows for the three month periods ended March 31, 2023 and 2022:
  Three Months Ended March 31, 2023
  Available
for Sale
Assets		 Future Policy Benefits Foreign
Exchange		 Pension
Adjustments		 Total
Balance at January 1, 2023
$ (1,420,672) $ (1,369,204) $ (1,681) $ 1,244  $ (2,790,313)
Other comprehensive income (loss) before reclassifications, net of tax 378,162  (569,503) (5,148) —  (196,489)
Reclassifications, net of tax 25,746  —  —  (37) 25,709 
Other comprehensive income (loss) 403,908  (569,503) (5,148) (37) (170,780)
Balance at March 31, 2023
$ (1,016,764) $ (1,938,707) $ (6,829) $ 1,207  $ (2,961,093)


  Three Months Ended March 31, 2022
  Available
for Sale
Assets		 Future Policy Benefits Foreign
Exchange		 Pension
Adjustments		 Total
Balance at January 1, 2022
$ 2,765,290  $ (6,915,910) $ 19,248  $ (103,676) $ (4,235,048)
Other comprehensive income (loss) before reclassifications, net of tax (1,811,185) 2,216,355  3,341  —  408,511 
Reclassifications, net of tax (3,184) —  —  2,715  (469)
Other comprehensive income (loss) (1,814,369) 2,216,355  3,341  2,715  408,042 
Balance at March 31, 2022
$ 950,921  $ (4,699,555) $ 22,589  $ (100,961) $ (3,827,006)

12
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Reclassification Adjustments: Reclassification adjustments out of Accumulated Other Comprehensive Income are presented below for the three month periods ended March 31, 2023 and 2022.
   Three Months Ended March 31, Affected line items in the Statements of Operations
Component Line Item 2023 2022
Unrealized investment (gains) losses on available for sale assets:
Realized (gains) losses $ 33,124  $ (4,937) Realized (gains) losses
Amortization of (discount) premium (534) 907  Net investment income
Total before tax 32,590  (4,030)
Tax (6,844) 846  Income taxes
Total after-tax 25,746  (3,184)
Pension adjustments:
Amortization of prior service cost 269  158  Other operating expense
Amortization of actuarial (gain) loss (317) 3,279  Other operating expense
Total before tax (48) 3,437 
Tax 11  (722) Income taxes
Total after-tax (37) 2,715 
Total reclassification (after-tax)
$ 25,709  $ (469)
13
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 4—Investments

Portfolio Composition: Summaries of fixed maturities available for sale by amortized cost, fair value, and allowance for credit losses at March 31, 2023 and December 31, 2022, and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income (loss) are as follows. Redeemable preferred stock is included within "Corporates, by sector."
At March 31, 2023

Amortized
Cost		 Allowance for Credit Losses Gross
Unrealized
Gains		 Gross
Unrealized
Losses
Fair
 Value(1)
% of Total
Fixed
Maturities(2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 389,441  $ —  $ 114  $ (27,482) $ 362,073  2 
States, municipalities, and political subdivisions 2,894,161  —  41,407  (426,929) 2,508,639  15 
Foreign governments 53,789  —  13  (11,282) 42,520  — 
Corporates, by sector:
Financial 4,973,445  (26,040) 84,796  (453,394) 4,578,807  27 
Utilities 1,958,888  —  70,798  (94,579) 1,935,107  11 
Energy 1,434,766  —  38,477  (80,338) 1,392,905  8 
Other corporate sectors 6,697,469  (6,727) 126,968  (557,390) 6,260,320  36 
Total corporates 15,064,568  (32,767) 321,039  (1,185,701) 14,167,139  82 
Collateralized debt obligations 36,778  —  8,724  —  45,502  — 
Other asset-backed securities 87,966  —  4  (6,958) 81,012  1 
Total fixed maturities
$ 18,526,703  $ (32,767) $ 371,301  $ (1,658,352) $ 17,206,885  100 
(1)Amount reported in the balance sheet.
(2)At fair value.

The Company has exposure to banks as part of its fixed maturity portfolio. The Company’s bank securities had a fair value of $1.3 billion (8% of the total fixed maturity portfolio) at March 31, 2023 and December 31, 2022.


14
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
At December 31, 2022
Amortized
Cost		 Allowance for Credit Losses Gross
Unrealized
Gains		 Gross
Unrealized
Losses
Fair
 Value(1)
% of Total
Fixed
Maturities(2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 394,439  $ —  $ 27  $ (38,968) $ 355,498  2 
States, municipalities, and political subdivisions 2,791,030  —  24,328  (505,447) 2,309,911  14 
Foreign governments 55,164  —  6  (12,706) 42,464  — 
Corporates, by sector:
Financial 4,907,794  —  63,126  (504,489) 4,466,431  27 
Utilities 1,924,190  —  36,670  (125,713) 1,835,147  11 
Energy 1,436,598  —  22,637  (101,923) 1,357,312  8 
Other corporate sectors 6,667,043  —  78,903  (738,772) 6,007,174  37 
Total corporates 14,935,625  —  201,336  (1,470,897) 13,666,064  83 
Collateralized debt obligations 37,098  —  13,266  —  50,364  — 
Other asset-backed securities 88,336  —  4  (9,276) 79,064  1 
Total fixed maturities
$ 18,301,692  $ —  $ 238,967  $ (2,037,294) $ 16,503,365  100 
(1)Amount reported in the balance sheet.
(2)At fair value.

A schedule of fixed maturities available for sale by contractual maturity date at March 31, 2023, is shown below on an amortized cost basis, net of allowance for credit losses, and on a fair value basis. Actual disposition dates could differ from contractual maturities due to call or prepayment provisions.
At March 31, 2023
Amortized
Cost, net		 Fair
Value
Fixed maturities available for sale:
Due in one year or less $ 169,491  $ 170,003 
Due after one year through five years 1,113,684  1,118,421 
Due after five years through ten years 1,691,785  1,717,908 
Due after ten years through twenty years 7,976,112  7,740,695 
Due after twenty years 7,418,120  6,333,344 
Mortgage-backed and asset-backed securities 124,744  126,514 
$ 18,493,936  $ 17,206,885 

15
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Analysis of Investment Operations: "Net investment income" for the three month periods ended March 31, 2023 and 2022 is summarized as follows:
Three Months Ended
March 31,
2023 2022 % Change
Fixed maturities available for sale $ 232,299  $ 225,284  3 
Policy loans 11,755  11,428  3 
Other long-term investments(1)
 15,743  12,713  24 
Short-term investments 1,595  2 
261,392  249,427  5 
Less investment expense (4,287) (4,533) (5)
Net investment income
$ 257,105  $ 244,894  5 
(1)For the three months ended March 31, 2023 and 2022, the investment funds, accounted for under the fair value option method, recorded $11.3 million and $10.7 million of distributions, respectively, in net investment income. Refer to Other Long-Term Investments below for further discussion on the investment funds.


Selected information about sales of fixed maturities available for sale is as follows:
Three Months Ended
March 31,
2023 2022
Fixed maturities available for sale:
Proceeds from sales(1)
 $ 15,705  $ 75,116 
Gross realized gains —  773 
Gross realized losses (358) (3,679)
(1)There were no unsettled sales in the periods ended March 31, 2023 and 2022.


An analysis of "Realized gains (losses)" is as follows:
Three Months Ended
March 31,
2023 2022
Realized investment gains (losses):
Fixed maturities available for sale:
Sales and other(1)
 $ (357) $ 4,549 
Provision for credit losses (32,767) 387 
Fair value option—change in fair value 1,858  (5,338)
Other investments 339  (6,842)
Realized gains (losses) from investments
(30,927) (7,244)
Applicable tax 6,495  1,521 
Realized gains (losses), net of tax
$ (24,432) $ (5,723)
(1)During the three months ended March 31, 2023 and 2022, the Company recorded $0 and $0 of exchanges of fixed maturities (noncash transactions) that resulted in $0 and $0, respectively, in realized gains (losses).

16
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fair Value Measurements: The following tables represent the fair value of fixed maturities measured on a recurring basis at March 31, 2023 and December 31, 2022:
Fair Value Measurement at March 31, 2023 Using:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)		 Significant Other
Observable
Inputs (Level 2)		 Significant
Unobservable
Inputs (Level 3)		 Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises $ —  $ 362,073  $ —  $ 362,073 
States, municipalities, and political subdivisions —  2,508,639  —  2,508,639 
Foreign governments —  42,520  —  42,520 
Corporates, by sector:
Financial —  4,445,091  133,716  4,578,807 
Utilities —  1,822,748  112,359  1,935,107 
Energy —  1,381,989  10,916  1,392,905 
Other corporate sectors —  6,045,672  214,648  6,260,320 
Total corporates —  13,695,500  471,639  14,167,139 
Collateralized debt obligations —  —  45,502  45,502 
Other asset-backed securities —  81,012  —  81,012 
Total fixed maturities
$ —  $ 16,689,744  $ 517,141  $ 17,206,885 
Percentage of total —  % 97  % 3  % 100  %

Fair Value Measurement at December 31, 2022 Using:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)		 Significant Other
Observable
Inputs (Level 2)		 Significant
Unobservable
Inputs (Level 3)		 Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises $ —  $ 355,498  $ —  $ 355,498 
States, municipalities, and political subdivisions —  2,309,911  —  2,309,911 
Foreign governments —  42,464  —  42,464 
Corporates, by sector:
Financial —  4,332,495  133,936  4,466,431 
Utilities —  1,723,832  111,315  1,835,147 
Energy —  1,346,212  11,100  1,357,312 
Other corporate sectors —  5,785,442  221,732  6,007,174 
Total corporates —  13,187,981  478,083  13,666,064 
Collateralized debt obligations —  —  50,364  50,364 
Other asset-backed securities —  79,064  —  79,064 
Total fixed maturities
$ —  $ 15,974,918  $ 528,447  $ 16,503,365 
Percentage of total —  % 97  % 3  % 100  %

17
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables represent changes in fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
 Collateralized
Debt
Obligations		 Corporates Total
Balance at January 1, 2023
$ —  $ 50,364  $ 478,083  $ 528,447 
Included in realized gains / losses —  —  —  — 
Included in other comprehensive income —  (4,542) 5,370  828 
Acquisitions —  —  —  — 
Sales —  —  —  — 
Amortization —  1,141  2  1,143 
Other(1)
 —  (1,461) (11,816) (13,277)
Transfers into Level 3(2)
 —  —  —  — 
Transfers out of Level 3(2)
 —  —  —  — 
Balance at March 31, 2023
$ —  $ 45,502  $ 471,639  $ 517,141 
Percent of total fixed maturities —  % —  % 3  % 3  %
(1)Includes capitalized interest, foreign exchange adjustments, and principal repayments. 
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
 Collateralized
Debt
Obligations		 Corporates Total
Balance at January 1, 2022
$ —  $ 63,505  $ 641,688  $ 705,193 
Included in realized gains / losses —  —  —  — 
Included in other comprehensive income —  (3,809) (36,360) (40,169)
Acquisitions —  —  —  — 
Sales —  —  —  — 
Amortization —  1,123  1  1,124 
Other(1)
 —  (1,281) (19,359) (20,640)
Transfers into Level 3(2)
 —  —  —  — 
Transfers out of Level 3(2)
 —  —  —  — 
Balance at March 31, 2022
$ —  $ 59,538  $ 585,970  $ 645,508 
Percent of total fixed maturities —  % —  % 3  % 3  %
(1)Includes capitalized interest, foreign exchange adjustments, and principal repayments. 
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

18
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents changes in unrealized gains and losses for the period included in accumulated other comprehensive income for assets held at the end of the reporting period for Level 3s:
Changes in Unrealized Gains (Losses) included in Accumulated Other Comprehensive Income for Assets Held at the End of the Period
Asset-
backed Securities		 Collateralized
Debt
Obligations		 Corporates Total
At March 31, 2023
 $ —  $ (4,542) $ 5,370  $ 828 
At March 31, 2022
 —  (3,809) (36,360) (40,169)
 
Unrealized Loss Analysis: The following table discloses information about fixed maturities available for sale in an unrealized loss position.
Less than Twelve Months Twelve Months or Longer Total
Number of issues (CUSIPs) held:
As of March 31, 2023 624  1,290  1,914 
As of December 31, 2022 1,819  157  1,976 
 
Globe Life's entire fixed maturity portfolio consisted of 2,379 issues by 987 different issuers at March 31, 2023 and 2,328 issues by 979 different issuers at December 31, 2022. The weighted-average quality rating of all unrealized loss positions at amortized cost was A- as of March 31, 2023 and December 31, 2022.

The following tables disclose unrealized investment losses by class and major sector of fixed maturities available for sale at March 31, 2023 and December 31, 2022.
19
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

Analysis of Gross Unrealized Investment Losses
At March 31, 2023
Less than Twelve Months Twelve Months or Longer Total
Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 275,114  $ (17,384) $ 84,691  $ (10,098) $ 359,805  $ (27,482)
States, municipalities, and political subdivisions 601,542  (23,575) 1,219,137  (403,354) 1,820,679  (426,929)
Foreign governments 15,491  (145) 25,555  (11,137) 41,046  (11,282)
Corporates, by sector:
Financial 1,355,645  (92,771) 1,482,482  (308,161) 2,838,127  (400,932)
Utilities 304,897  (14,438) 474,873  (77,678) 779,770  (92,116)
Energy 319,199  (11,489) 332,106  (58,433) 651,305  (69,922)
Other corporate sectors 1,211,339  (64,035) 2,859,975  (470,663) 4,071,314  (534,698)
Total corporates 3,191,080  (182,733) 5,149,436  (914,935) 8,340,516  (1,097,668)
Collateralized debt obligations —  —  —  —  —  — 
Other asset-backed securities 25,733  (696) 43,631  (5,454) 69,364  (6,150)
Total investment grade securities 4,108,960  (224,533) 6,522,450  (1,344,978) 10,631,410  (1,569,511)
Below investment grade securities:
States, municipalities, and political subdivisions —  —  —  —  —  — 
Corporates, by sector:
Financial 79,716  (9,059) 106,971  (43,403) 186,687  (52,462)
Utilities 8,265  (662) 20,166  (1,801) 28,431  (2,463)
Energy —  —  34,289  (10,416) 34,289  (10,416)
Other corporate sectors 71,156  (4,350) 90,580  (18,342) 161,736  (22,692)
Total corporates 159,137  (14,071) 252,006  (73,962) 411,143  (88,033)
Collateralized debt obligations —  —  —  —  —  — 
Other asset-backed securities —  —  11,580  (808) 11,580  (808)
Total below investment grade securities 159,137  (14,071) 263,586  (74,770) 422,723  (88,841)
Total fixed maturities
$ 4,268,097  $ (238,604) $ 6,786,036  $ (1,419,748) $ 11,054,133  $ (1,658,352)
 
Gross unrealized losses may fluctuate quarter over quarter due to adverse factors in the market that affect our holdings, such as changes in interest rates or credit spreads. The Company considers many factors when determining whether an allowance for a credit loss should be recorded. While the Company holds securities that may be in an unrealized loss position from time to time, Globe Life does not generally intend to sell and it is likely that management will not be required to sell the fixed maturities prior to their anticipated recovery or maturity due to the strong cash flows generated by its insurance operations.

20
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Analysis of Gross Unrealized Investment Losses
At December 31, 2022
Less than Twelve Months Twelve Months or Longer Total
Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss		 Fair
Value		 Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 349,887  $ (38,218) $ 3,424  $ (750) $ 353,311  $ (38,968)
States, municipalities, and political subdivisions 1,767,624  (453,149) 95,124  (52,298) 1,862,748  (505,447)
Foreign governments 6,297  (201) 25,134  (12,505) 31,431  (12,706)
Corporates, by sector:
Financial 2,837,918  (426,132) 109,784  (42,173) 2,947,702  (468,305)
Utilities 1,088,219  (116,272) 21,636  (6,268) 1,109,855  (122,540)
Energy 855,853  (91,755) —  —  855,853  (91,755)
Other corporate sectors 4,155,986  (665,831) 94,299  (42,344) 4,250,285  (708,175)
Total corporates 8,937,976  (1,299,990) 225,719  (90,785) 9,163,695  (1,390,775)
Collateralized debt obligations —  —  —  —  —  — 
Other asset-backed securities 60,157  (5,223) 7,960  (2,435) 68,117  (7,658)
Total investment grade securities 11,121,941  (1,796,781) 357,361  (158,773) 11,479,302  (1,955,554)
Below investment grade securities:
States, municipalities, and political subdivisions —  —  —  —  —  — 
Corporates, by sector:
Financial 120,377  (18,901) 38,348  (17,283) 158,725  (36,184)
Utilities 27,722  (3,173) —  —  27,722  (3,173)
Energy 14,480  (2,182) 20,075  (7,986) 34,555  (10,168)
Other corporate sectors 166,159  (25,962) 6,670  (4,635) 172,829  (30,597)
Total corporates 328,738  (50,218) 65,093  (29,904) 393,831  (80,122)
Collateralized debt obligations —  —  —  —  —  — 
Other asset-backed securities —  —  10,874  (1,618) 10,874  (1,618)
Total below investment grade securities 328,738  (50,218) 75,967  (31,522) 404,705  (81,740)
Total fixed maturities
$ 11,450,679  $ (1,846,999) $ 433,328  $ (190,295) $ 11,884,007  $ (2,037,294)

21
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fixed Maturities, Allowance for Credit Losses: A summary of the activity in the allowance for credit losses is as follows.
Three Months Ended
March 31,
2023 2022
Allowance for credit losses beginning balance
$ —  $ 387 
Additions to allowance for which credit losses were not previously recorded 32,767  — 
Additions (reductions) to allowance for fixed maturities that previously had an allowance —  — 
Reduction of allowance for which the Company intends to sell or more likely than not will be required to sell or sold during the period —  (387)
Allowance for credit losses ending balance
$ 32,767  $ — 

As of March 31, 2023 and December 31, 2022, the Company did not have any fixed maturities in non-accrual status.

Other Long-Term Investments: Other long-term investments consist of the following assets:
March 31,
2023		 December 31, 2022
Investment funds $ 789,197  $ 768,689 
Commercial mortgage loan participations 204,275  181,305 
Other 29,139  26,022 
Total
$ 1,022,611  $ 976,016 

The following table presents additional information about the Company's investment funds as of March 31, 2023 and December 31, 2022 at fair value:
Fair Value Unfunded Commitments
Investment Category March 31,
2023		 December 31, 2022 March 31,
2023		 Redemption Term/Notice
Commercial mortgage loans $ 454,144  $ 431,405  $ 330,245  Fully redeemable and non-redeemable with varying terms.
Opportunistic credit 157,899  158,524  — 
Initial 2 year lock on each new investment/semi-annual withdrawals thereafter/full redemption within 36 month period.
Infrastructure 158,036  159,534  21,366  Fully redeemable and non-redeemable with varying terms.
Other 19,118  19,226  120,079   
Total investment funds $ 789,197  $ 768,689  $ 471,690 

The Company had $21 million of capital called during the year from existing investment funds. Our unfunded commitments were $472 million as of March 31, 2023.


22
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Commercial Mortgage Loan Participations (commercial mortgage loans): Summaries of commercial mortgage loans by property type and geographical location at March 31, 2023 and December 31, 2022 are as follows:
March 31, 2023 December 31, 2022
Carrying Value % of Total Carrying Value % of Total
Property type:
Mixed use $ 59,965  29  $ 62,375  34 
Hospitality 28,033  14  27,796  15 
Retail 23,744  12  15,342  9 
Industrial 27,259  13  27,248  15 
Multi-family 57,206  28  42,232  23 
Office 11,137  6  8,101  5 
Total recorded investment 207,344  102  183,094  101 
Less allowance for credit losses (3,069) (2) (1,789) (1)
Carrying value, net of allowance for credit losses
$ 204,275  100  $ 181,305  100 

March 31, 2023 December 31, 2022
Carrying Value % of Total Carrying Value % of Total
Geographic location:
California $ 64,990  32  $ 64,477  36 
Texas 23,132  12  22,905  13 
New York 27,570  14  19,167  11 
Washington 14,939  7  14,925  8 
Massachusetts 14,925  7  —  — 
Florida 33,217  16  33,182  18 
Other 28,571  14  28,438  15 
Total recorded investment 207,344  102  183,094  101 
Less allowance for credit losses (3,069) (2) (1,789) (1)
Carrying value, net of allowance for credit losses
$ 204,275  100  $ 181,305  100 
23
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables are reflective of the key factors, debt service coverage ratios, and loan-to-value (LTV) ratios that are utilized by management to monitor the performance of the portfolios. The Company only makes new investments in commercial mortgage loans that have a LTV ratio less than 80%. Generally, a higher LTV ratio and a lower debt service coverage ratio can potentially equate to higher risk of loss.
March 31, 2023
Recorded Investment
Debt Service Coverage Ratios(1)
<1.00x 1.00x—1.20x >1.20x Total % of Total
Loan-to-value ratio(2):
Less than 70% $ 24,235  $ 123,466  $ 20,430  $ 168,131  81 
70% to 80% —  7,222  1,238  8,460  4 
81% to 90% 8,307  —  —  8,307  4 
Greater than 90% 7,035  15,411  —  22,446  11 
Total $ 39,577  $ 146,099  $ 21,668  207,344  100 
Less allowance for credit losses (3,069)
Total, net of allowance for credit losses
$ 204,275 
(1)Annual net operating income divided by annual mortgage debt service (principal and interest).
(2)Loan balance divided by appraised value, including planned renovations and stabilized occupancy, at origination. Updated internal valuations are used when a loan is materially underperforming.

December 31, 2022
Recorded Investment
Debt Service Coverage Ratios(1)
<1.00x 1.00x—1.20x >1.20x Total % of Total
Loan-to-value ratio(2):
Less than 70% $ 24,221  $ 108,156  $ 12,018  $ 144,395  79 
70% to 80% —  22,120  1,238  23,358  13 
81% to 90% 8,307  —  —  8,307  4 
Greater than 90% 7,034  —  —  7,034  4 
Total $ 39,562  $ 130,276  $ 13,256  183,094  100 
Less allowance for credit losses (1,789)
Total, net of allowance for credit losses
$ 181,305 
(1)Annual net operating income divided by annual mortgage debt service (principal and interest).
(2)Loan balance divided by appraised value, including planned renovations and stabilized occupancy, at origination. Updated internal valuations are used when a loan is materially underperforming.

As of March 31, 2023, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 25 loans in the portfolio. For the three months ended March 31, 2023, the allowance for credit losses increased $1.3 million. The provision for credit losses is included in "Realized gains (losses)" in the Condensed Consolidated Statements of Operations.
Three Months Ended
March 31,
2023 2022
Allowance for credit losses beginning balance
$ 1,789  $ 827 
Provision (reversal) for credit losses 1,280  — 
Allowance for credit losses ending balance
$ 3,069  $ 827 

24
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
There were no delinquent commercial mortgage loans as of March 31, 2023 and December 31, 2022. As of March 31, 2023 and December 31, 2022, the Company had no commercial mortgage loan in non-accrual status. The Company's unfunded commitment balance to commercial loan borrowers was $28 million as of March 31, 2023.


Note 5—Commitments and Contingencies

Guarantees: The Parent Company has guaranteed letters of credit in connection with its credit facility with a group of banks. The letters of credit were issued by TMK Re, Ltd., a wholly-owned subsidiary, to secure TMK Re, Ltd.’s obligation for claims on certain policies reinsured by TMK Re, Ltd. that were sold by other Globe Life insurance subsidiaries. These letters of credit facilitate TMK Re, Ltd.’s ability to reinsure the business of Globe Life's insurance carriers. The agreement was amended on September 30, 2021 and now expires in 2026. The maximum amount of letters of credit available is $250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. The amount outstanding at March 31, 2023 was $115 million.

Litigation: Globe Life Inc. and its subsidiaries, in common with the insurance industry in general, are subject to litigation, including putative class action litigation, alleged breaches of contract, torts, including bad faith and fraud claims based on alleged wrongful or fraudulent acts of agents of the Parent Company's insurance subsidiaries, employment discrimination, and miscellaneous other causes of action. Based upon information presently available, and in light of legal and other factual defenses available to the Parent Company and its subsidiaries, management does not believe that it is reasonably possible that such litigation will have a material adverse effect on Globe Life's financial condition, future operating results or liquidity; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future. This bespeaks caution, particularly in states with reputations for high punitive damage verdicts. Globe Life's management recognizes that large punitive damage awards bearing little or no relation to actual damages continue to be awarded by juries in jurisdictions in which the Company has substantial business, creating the potential for unpredictable material adverse judgments in any given punitive damage suit.

25
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 6—Policy Liabilities

The liability for future policy benefits is determined based on the net level premium method, which requires the liability be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders.

The following tables summarize balances and changes in the net liability for future policy benefits, before reinsurance, for traditional life long-duration contracts:
Life
Present value of expected future net premiums
American Income DTC Liberty National Other Total
Balance at January 1, 2022
$ 4,925,192  $ 7,264,905  $ 1,332,469  $ 559,972  $ 14,082,538 
Beginning balance at original discount rates 3,906,098  5,533,741  1,040,242  416,141  10,896,222 
Effect of changes in assumptions of future cash flows —  —  —  —  — 
Effect of actual variances from expected experience (4,315) (29,595) (625) 1,652  (32,883)
Adjusted balance at January 1, 2022
3,901,783  5,504,146  1,039,617  417,793  10,863,339 
Issuances(1)
 215,926  173,775  22,965  7,300  419,966 
Interest accrual(2)
 43,074  67,608  12,810  5,172  128,664 
Net premiums collected(3)
 (120,203) (149,757) (31,627) (10,831) (312,418)
Effect of changes in the foreign exchange rate 2,900  —  —  —  2,900 
Ending balance at original discount rates 4,043,480  5,595,772  1,043,765  419,434  11,102,451 
Effect of change from original to current discount rates 603,267  1,114,883  181,223  92,398  1,991,771 
Balance at March 31, 2022
$ 4,646,747  $ 6,710,655  $ 1,224,988  $ 511,832  $ 13,094,222 
Balance at January 1, 2023
$ 4,273,156  $ 5,910,224  $ 1,094,407  $ 470,741  $ 11,748,528 
Beginning balance at original discount rates 4,246,723  5,680,864  1,066,123  449,209  11,442,919 
Effect of changes in assumptions of future cash flows —  —  —  —  — 
Effect of actual variances from expected experience (29,981) (47,988) (5,590) (1,886) (85,445)
Adjusted balance at January 1, 2023
4,216,742  5,632,876  1,060,533  447,323  11,357,474 
Issuances(1)
 192,555  168,952  30,142  7,241  398,890 
Interest accrual(2)
 47,898  70,991  13,288  5,670  137,847 
Net premiums collected(3)
 (127,239) (153,919) (33,188) (11,557) (325,903)
Effect of changes in the foreign exchange rate (3,999) —  —  —  (3,999)
Ending balance at original discount rates 4,325,957  5,718,900  1,070,775  448,677  11,564,309 
Effect of change from original to current discount rates 141,680  391,650  57,308  34,379  625,017 
Balance at March 31, 2023
$ 4,467,637  $ 6,110,550  $ 1,128,083  $ 483,056  $ 12,189,326 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio, and the gross premiums collected during the period on the in-force business.




26
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future policy benefits
American Income DTC Liberty National Other Total
Balance at January 1, 2022
$ 11,773,519  $ 11,859,408  $ 4,542,697  $ 5,488,684  $ 33,664,308 
Beginning balance at original discount rates 7,744,201  8,157,259  3,206,164  3,267,306  22,374,930 
Effect of changes in assumptions of future cash flows —  —  —  —  — 
Effect of actual variances from expected experience (2,959) (25,850) 153  1,680  (26,976)
Adjusted balance at January 1, 2022
7,741,242  8,131,409  3,206,317  3,268,986  22,347,954 
Issuances(1)
 215,926  173,775  22,965  7,300  419,966 
Interest accrual(2)
 100,336  106,928  42,230  48,280  297,774 
Benefit payments(3)
 (104,321) (173,611) (63,457) (34,297) (375,686)
Effect of changes in the foreign exchange rate 6,511  —  —  —  6,511 
Ending balance at original discount rates 7,959,694  8,238,501  3,208,055  3,290,269  22,696,519 
Effect of change from original to current discount rates 2,692,562  2,511,848  858,179  1,558,106  7,620,695 
Balance at March 31, 2022
$ 10,652,256  $ 10,750,349  $ 4,066,234  $ 4,848,375  $ 30,317,214 

Balance at January 1, 2023
$ 9,119,104  $ 9,225,451  $ 3,429,256  $ 3,976,150  $ 25,749,961 
Beginning balance at original discount rates 8,409,761  8,477,892  3,272,980  3,403,704  23,564,337 
Effect of changes in assumptions of future cash flows —  —  —  —  — 
Effect of actual variances from expected experience (31,526) (48,947) (7,054) (2,896) (90,423)
Adjusted balance at January 1, 2023
8,378,235  8,428,945  3,265,926  3,400,808  23,473,914 
Issuances(1)
 192,555  168,952  30,142  7,241  398,890 
Interest accrual(2)
 109,329  112,768  43,256  50,378  315,731 
Benefit payments(3)
 (96,674) (147,061) (54,730) (30,892) (329,357)
Effect of changes in the foreign exchange rate (9,711) —  —  —  (9,711)
Ending balance at original discount rates 8,573,734  8,563,604  3,284,594  3,427,535  23,849,467 
Effect of change from original to current discount rates 1,063,729  1,061,076  274,418  738,992  3,138,215 
Balance at March 31, 2023
$ 9,637,463  $ 9,624,680  $ 3,559,012  $ 4,166,527  $ 26,987,682 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, lapse, and maturity benefit payments based on the revised expected assumptions.

27
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Net liability for future policy benefits as of March 31, 2022
American Income DTC Liberty National Other Total
Net liability for future policy benefits at original discount rates
$ 3,916,214  $ 2,642,729  $ 2,164,290  $ 2,870,835  $ 11,594,068 
Effect of changes in discount rate assumptions 2,089,295  1,396,965  676,956  1,465,708  5,628,924 
Net liability for future policy benefits at current discount rates
6,005,509  4,039,694  2,841,246  4,336,543  17,222,992 
Other Adjustments(1)
 (11) 2,820  (10,446) (43,598) (51,235)
Net liability for future policy benefits, after other adjustments, at current discount rates
$ 6,005,498  $ 4,042,514  $ 2,830,800  $ 4,292,945  $ 17,171,757 

(1)Other adjustments include the Company's reinsurance recoverable and the effects of capping and flooring the liability.

Life
Net liability for future policy benefits as of March 31, 2023
American Income DTC Liberty National Other Total
Net liability for future policy benefits at original discount rates
$ 4,247,777  $ 2,844,704  $ 2,213,819  $ 2,978,858  $ 12,285,158 
Effect of changes in discount rate assumptions 922,049  669,426  217,110  704,613  2,513,198 
Net liability for future policy benefits at current discount rates
5,169,826  3,514,130  2,430,929  3,683,471  14,798,356 
Other Adjustments(1)
 (46) 4,546  486  (36,765) (31,779)
Net liability for future policy benefits, after other adjustments, at current discount rates
$ 5,169,780  $ 3,518,676  $ 2,431,415  $ 3,646,706  $ 14,766,577 

(1)Other adjustments include the Company's reinsurance recoverable and the effects of capping and flooring the liability.
28
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables summarize balances and changes in the net liability for future policy benefits for long-duration health contracts:
Health
Present value of expected future net premiums
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2022
$ 3,611,659  $ 1,944,714  $ 517,368  $ 222,553  $ 121,724  $ 6,418,018 
Beginning balance at original discount rates 2,949,851  1,688,590  414,409  178,801  96,776  5,328,427 
Effect of changes in assumptions of future cash flows —  —  —  —  —  — 
Effect of actual variances from expected experience (49,560) (15,162) (15,462) (2,465) (1,880) (84,529)
Adjusted balance at January 1, 2022
2,900,291  1,673,428  398,947  176,336  94,896  5,243,898 
Issuances(1)
 90,034  53,518  10,815  10,452  880  165,699 
Interest accrual(2)
 30,339  14,940  4,872  1,831  1,182  53,164 
Net premiums collected(3)
 (62,895) (42,751) (12,883) (5,252) (2,550) (126,331)
Effect of changes in the foreign exchange rate —  —  —  312  —  312 
Ending balance at original discount rates 2,957,769  1,699,135  401,751  183,679  94,408  5,336,742 
Effect of change from original to current discount rates 379,383  91,102  61,701  24,385  15,326  571,897 
Balance at March 31, 2022
$ 3,337,152  $ 1,790,237  $ 463,452  $ 208,064  $ 109,734  $ 5,908,639 
Balance at January 1, 2023
$ 2,908,501  $ 1,594,992  $ 423,490  $ 190,296  $ 90,143  $ 5,207,422 
Beginning balance at original discount rates 2,941,261  1,729,219  415,442  192,631  87,751  5,366,304 
Effect of changes in assumptions of future cash flows —  —  —  —  —  — 
Effect of actual variances from expected experience (34,132) (18,758) (16,585) (1,621) (2,573) (73,669)
Adjusted balance at January 1, 2023
2,907,129  1,710,461  398,857  191,010  85,178  5,292,635 
Issuances(1)
 75,839  67,787  13,303  10,212  2,392  169,533 
Interest accrual(2)
 31,587  16,199  4,890  2,036  1,057  55,769 
Net premiums collected(3)
 (65,914) (43,979) (12,403) (5,424) (2,661) (130,381)
Effect of changes in the foreign exchange rate —  —  —  (388) —  (388)
Ending balance at original discount rates 2,948,641  1,750,468  404,647  197,446  85,966  5,387,168 
Effect of change from original to current discount rates 49,082  (86,054) 16,800  3,220  4,277  (12,675)
Balance at March 31, 2023
$ 2,997,723  $ 1,664,414  $ 421,447  $ 200,666  $ 90,243  $ 5,374,493 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio, and the gross premiums collected during the period on the in-force business.









29
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future policy benefits
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2022
$ 3,810,559  $ 3,840,322  $ 1,201,317  $ 380,915  $ 119,888  $ 9,353,001 
Beginning balance at original discount rates 3,090,901  3,193,342  921,608  285,604  95,628  7,587,083 
Effect of changes in assumptions of future cash flows —  —  —  —  —  — 
Effect of actual variances from expected experience (50,453) (15,668) (15,790) (2,645) (2,025) (86,581)
Adjusted balance at January 1, 2022
3,040,448  3,177,674  905,818  282,959  93,603  7,500,502 
Issuances(1)
 89,904  53,518  10,866  10,452  876  165,616 
Interest accrual(2)
 32,308  29,583  12,120  3,432  1,182  78,625 
Benefit payments(3)
 (67,243) (28,494) (23,065) (5,044) (3,389) (127,235)
Effect of changes in the foreign exchange rate —  —  —  557  —  557 
Ending balance at original discount rates 3,095,417  3,232,281  905,739  292,356  92,272  7,618,065 
Effect of change from original to current discount rates 413,068  244,358  176,686  59,275  14,762  908,149 
Balance at March 31, 2022
$ 3,508,485  $ 3,476,639  $ 1,082,425  $ 351,631  $ 107,034  $ 8,526,214 

Balance at January 1, 2023
$ 3,046,829  $ 3,005,664  $ 941,574  $ 312,750  $ 87,532  $ 7,394,349 
Beginning balance at original discount rates 3,080,633  3,336,344  904,865  303,713  85,212  7,710,767 
Effect of changes in assumptions of future cash flows —  —  —  —  —  — 
Effect of actual variances from expected experience (31,443) (19,779) (15,995) (1,578) (2,302) (71,097)
Adjusted balance at January 1, 2023
3,049,190  3,316,565  888,870  302,135  82,910  7,639,670 
Issuances(1)
 75,683  67,787  13,285  10,212  2,388  169,355 
Interest accrual(2)
 33,480  32,289  11,840  3,668  1,057  82,334 
Benefit payments(3)
 (78,563) (29,261) (23,976) (7,137) (3,354) (142,291)
Effect of changes in the foreign exchange rate —  —  —  (708) —  (708)
Ending balance at original discount rates 3,079,790  3,387,380  890,019  308,170  83,001  7,748,360 
Effect of change from original to current discount rates 52,672  (212,708) 59,977  18,363  4,089  (77,607)
Balance at March 31, 2023
$ 3,132,462  $ 3,174,672  $ 949,996  $ 326,533  $ 87,090  $ 7,670,753 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, lapse, and maturity benefit payments based on the revised expected assumptions.

30
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Net liability for future policy benefits as of March 31, 2022
United American Family Heritage Liberty National American Income Direct to Consumer Total
Net liability for future policy benefits at original discount rates
$ 137,648  $ 1,533,146  $ 503,988  $ 108,677  $ (2,136) $ 2,281,323 
Effect of changes in discount rate assumptions 33,685  153,256  114,985  34,890  (564) 336,252 
Net liability for future policy benefits at current discount rates
171,333  1,686,402  618,973  143,567  (2,700) 2,617,575 
Other Adjustments (1,812) (10,847) 1,508  12  3,812  (7,327)
Net liability for future policy benefits, after other adjustments, at current discount rates
$ 169,521  $ 1,675,555  $ 620,481  $ 143,579  $ 1,112  $ 2,610,248 
(1)Other adjustments include the Company's reinsurance recoverable and the effects of capping and flooring the liability.

Health
Net liability for future policy benefits as of March 31, 2023
United American Family Heritage Liberty National American Income Direct to Consumer Total
Net liability for future policy benefits at original discount rates
131,149  1,636,912  485,372  110,724  (2,965) 2,361,192 
Effect of changes in discount rate assumptions 3,590  (126,654) 43,177  15,143  (188) (64,932)
Net liability for future policy benefits at current discount rates
134,739  1,510,258  528,549  125,867  (3,153) 2,296,260 
Other Adjustments 1,771  (9,362) 4,348  333  4,162  1,252 
Net liability for future policy benefits, after other adjustments, at current discount rates
$ 136,510  $ 1,500,896  $ 532,897  $ 126,200  $ 1,009  $ 2,297,512 
(1)Other adjustments include the Company's reinsurance recoverable and the effects of capping and flooring the liability.


During the three-month periods ended March 31, 2023 and 2022, the Company's results for actual variances from expected experience produced a net reserve remeasurement gain of $659 thousand and a net reserve remeasurement loss of $3.8 million in the Condensed Consolidated Statements of Operations, respectively. The variance of actual experience from expected experience during the first quarter of 2023 was primarily due to favorable variances from mortality assumptions as compared to actual experience in our life insurance segment (a $2.7 million gain), and unfavorable variances from morbidity assumptions as compared to actual experience in our health insurance segment (a $2.0 million loss). The variance of actual experience from expected experience during the first quarter of 2022 was primarily due to unfavorable variances from mortality assumptions as compared to actual experience in our life insurance segment (a $5.8 million loss), and favorable variances from morbidity assumptions as compared to actual experience in our health insurance segment (a $2.0 million gain). The life segment has experienced lower claims in the first quarter of 2023 versus the prior year mainly driven by lower excess claims due to COVID and non-COVID causes, which was seen in the American Income, Direct to Consumer, and Liberty National channels. The health segment's utilization has returned to normal levels in 2023, specifically in the United American and Liberty National channels. There were no changes to the inputs, judgments, assumptions and methods used in measuring the liability for future policy benefits during the three-month periods ended March 31, 2023 and 2022.


31
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table reconciles the liability for future policy benefits to the Consolidated Balance Sheets as of March 31, 2023:
At Original Discount Rates At Current Discount Rates
As of March 31, As of March 31,
2023 2022 2023 2022
Life(1):
American Income $ 4,247,758  $ 3,916,187  $ 5,169,780  $ 6,005,498 
Direct to Consumer 2,844,707  2,642,729  3,518,676  4,042,514 
Liberty National 2,206,288  2,153,030  2,431,415  2,830,800 
Other 2,952,802  2,846,161  3,646,706  4,292,945 
Net liability for future policy benefits—long duration life 12,251,555  11,558,107  14,766,577  17,171,757 
Health(1):
United American 130,992  135,891  136,510  169,521 
Family Heritage 1,626,881  1,524,185  1,500,896  1,675,555 
Liberty National 488,546  505,319  532,897  620,481 
American Income 111,096  108,693  126,200  143,579 
Direct to Consumer 961  1,004  1,009  1,112 
Net liability for future policy benefits—long duration health 2,358,476  2,275,092  2,297,512  2,610,248 
Deferred profit liability 177,248  184,451  177,248  184,451 
Deferred annuity 907,797  1,027,087  907,797  1,027,087 
Interest sensitive life 737,900  744,244  737,900  744,244 
Other 9,540  8,118  9,540  8,118 
Total future policy benefits
$ 16,442,516  $ 15,797,099  $ 18,896,574  $ 21,745,905 
(1)Balances are presented net of the reinsurance recoverable and the effects of flooring the liability.

The following tables provide the weighted-average original and current discount rates for the liability for future policy benefits and the additional insurance liabilities for the periods ended March 31, 2023 and 2022:
Life
Weighted-average Discount Rates
March 31, 2023 March 31, 2022
American Income DTC Liberty National Other American Income DTC Liberty National Other
Original discount rate 5.8  % 6.0  % 5.6  % 6.2  % 5.8  % 6.0  % 5.6  % 6.2  %
Current discount rate 4.9  % 5.0  % 5.0  % 5.0  % 4.0  % 4.0  % 3.9  % 3.9  %

Health
Weighted-average Discount Rates
March 31, 2023 March 31, 2022
United American Family Heritage Liberty National American Income DTC United American Family Heritage Liberty National American Income DTC
Original discount rate 5.2  % 4.3  % 5.8  % 5.9  % 5.2  % 5.2  % 4.4  % 5.8  % 5.9  % 5.2  %
Current discount rate 4.8  % 4.9  % 4.9  % 4.8  % 4.8  % 3.8  % 3.9  % 3.6  % 3.8  % 3.8  %


32
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table provides the weighted-average durations of the liability for future policy benefits and the additional insurance liabilities for the periods ended March 31, 2023 and 2022:
March 31,
2023 2022
At original discount rates At current discount rates At original discount rates At current discount rates
Life
American Income 22.90 23.33 22.80 23.78
Direct to Consumer 20.24 21.82 20.81 22.93
Liberty National 14.94 15.63 15.08 16.85
Other 16.52 18.23 16.76 19.59
Health
United American 11.40 10.80 11.68 11.83
Family Heritage 14.91 14.43 15.28 15.80
Liberty National 9.31 9.66 9.01 10.11
American Income 12.15 12.74 12.45 13.95
Direct to Consumer 11.40 10.80 11.68 11.83

The following tables summarize the amount of gross premiums and interest, net of reinsurance, related to long duration life and health contracts that are recognized in the Condensed Consolidated Statements of Operations:
Life
Three Months Ended March 31, 2023 Three Months Ended March 31, 2022
Gross
Premiums		 Interest
expense		 Gross
Premiums		 Interest
expense
American Income $ 387,145  $ 61,431  $ 369,737  $ 57,262 
Direct to Consumer 244,707  41,714  242,662  39,292 
Liberty National 84,072  29,769  79,348  29,285 
Other 51,835  44,275  52,387  42,697 
Total $ 767,759  $ 177,189  $ 744,134  $ 168,536 

Health
Three Months Ended March 31, 2023 Three Months Ended March 31, 2022
Gross
Premiums		 Interest
expense		 Gross
Premiums		 Interest
expense
United American $ 97,833  $ 1,822  $ 92,266  $ 1,914 
Family Heritage 96,090  15,977  89,540  14,545 
Liberty National 46,745  6,920  47,496  7,226 
American Income 28,096  1,632  27,937  1,601 
Direct to Consumer 3,542  —  3,536  — 
Total $ 272,306  $ 26,351  $ 260,775  $ 25,286 

Gross premiums are included within life and health premium on the Condensed Consolidated Statements of Operations, while the related interest expense is included in life and health policyholder benefits.

33
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables provide the undiscounted and discounted expected future net premiums, expected future gross premiums and expected future policy benefits, at both original and current discount rates, for life and health contracts:
Life
Three Months Ended March 31, 2023 Three Months Ended March 31, 2022
Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates
American Income
PV of expected future net premiums $ 7,617,532  $ 4,325,957  $ 4,467,637  $ 7,115,131  $ 4,043,480  $ 4,646,747 
PV of expected future gross premiums 23,041,514  13,054,486  13,575,751  21,851,854  12,374,587  14,324,455 
PV of expected future policy benefits 28,821,998  8,573,734  9,637,463  26,930,450  7,959,694  10,652,256 
DTC
PV of expected future net premiums $ 10,832,386  $ 5,718,900  $ 6,110,550  $ 10,630,110  $ 5,595,772  $ 6,710,655 
PV of expected future gross premiums 17,479,516  9,165,113  9,773,835  17,414,120  9,103,648  10,912,941 
PV of expected future policy benefits 25,582,750  8,563,604  9,624,680  24,876,834  8,238,501  10,750,349 
Liberty National
PV of expected future net premiums $ 1,889,419  $ 1,070,775  $ 1,128,083  $ 1,855,371  $ 1,043,765  $ 1,224,988 
PV of expected future gross premiums 4,453,139  2,599,082  2,667,795  4,265,146  2,485,460  2,848,626 
PV of expected future policy benefits 8,658,766  3,284,594  3,559,012  8,514,395  3,208,055  4,066,234 
Other
PV of expected future net premiums $ 919,924  $ 448,677  $ 483,056  $ 869,727  $ 419,434  $ 511,832 
PV of expected future gross premiums 3,798,669  1,920,302  2,126,949  3,907,011  1,950,624  2,441,512 
PV of expected future policy benefits 12,392,224  3,427,535  4,166,527  12,277,130  3,290,269  4,848,375 
Total
PV of expected future net premiums $ 21,259,261  $ 11,564,309  $ 12,189,326  $ 20,470,339  $ 11,102,451  $ 13,094,222 
PV of expected future gross premiums 48,772,838  26,738,983  28,144,330  47,438,131  25,914,319  30,527,534 
PV of expected future policy benefits 75,455,738  23,849,467  26,987,682  72,598,809  22,696,519  30,317,214 

As of March 31, 2023 for the life segment using current discount rates, the Company anticipates $12.2 billion of expected future net premiums and $28.1 billion of expected future gross premiums. As of March 31, 2022 using current discount rates, the Company anticipated $13.1 billion in expected future net premiums and $30.5 billion of expected future gross premiums. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not.
.
34
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Three Months Ended March 31, 2023 Three Months Ended March 31, 2022
Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates
United American
PV of expected future net premiums $ 4,685,306  $ 2,948,641  $ 2,997,723  $ 4,763,592  $ 2,957,769  $ 3,337,152 
PV of expected future gross premiums 6,783,819  4,279,547  4,346,007  6,781,444  4,226,705  4,765,664 
PV of expected future policy benefits 4,909,212  3,079,790  3,132,462  5,057,861  3,095,417  3,508,485 
Family Heritage
PV of expected future net premiums $ 2,908,079  $ 1,750,468  $ 1,664,414  $ 2,784,235  $ 1,699,135  $ 1,790,237 
PV of expected future gross premiums 6,442,316  3,846,392  3,682,300  5,897,650  3,570,212  3,791,575 
PV of expected future policy benefits 6,358,594  3,387,380  3,174,672  6,004,155  3,232,281  3,476,639 
Liberty National
PV of expected future net premiums $ 634,061  $ 404,647  $ 421,447  $ 641,225  $ 401,751  $ 463,452 
PV of expected future gross premiums 2,232,290  1,396,334  1,468,763  2,174,779  1,356,873  1,577,158 
PV of expected future policy benefits 1,575,745  890,019  949,996  1,594,836  905,739  1,082,425 
American Income
PV of expected future net premiums $ 351,655  $ 197,446  $ 200,666  $ 323,828  $ 183,679  $ 208,064 
PV of expected future gross premiums 1,760,671  984,216  1,037,339  1,723,857  963,321  1,130,227 
PV of expected future policy benefits 626,151  308,170  326,533  599,187  292,356  351,631 
Direct to Consumer
PV of expected future net premiums $ 131,187  $ 85,966  $ 90,243  $ 148,614  $ 94,408  $ 109,734 
PV of expected future gross premiums 171,266  112,442  118,105  204,317  130,162  151,140 
PV of expected future policy benefits 124,597  83,001  87,090  143,711  92,272  107,034 
Total
PV of expected future net premiums 8,710,288  5,387,168  5,374,493  8,661,494  5,336,742  5,908,639 
PV of expected future gross premiums 17,390,362  10,618,931  10,652,514  16,782,047  10,247,273  11,415,764 
PV of expected future policy benefits 13,594,299  7,748,360  7,670,753  13,399,750  7,618,065  8,526,214 

As of March 31, 2023 for the health segment using current discount rates, the Company anticipates $5.4 billion of expected future net premiums and $10.6 billion of expected future gross premiums. As of March 31, 2022 using current discount rates, the Company anticipated $5.9 billion in expected future net premiums and $11.4 billion of expected future gross premiums. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not.


35
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table summarizes the balances of, and changes in, policyholders’ account balances as of March 31, 2023 and 2022:
Policyholders' Account Balances
2023 2022
Interest Sensitive Life Deferred Annuity Other Policyholders' Funds Interest Sensitive Life Deferred Annuity Other Policyholders' Funds
Balance at January 1,
$ 739,105  954,318  123,234  $ 745,335  $ 1,033,525  $ 99,468 
Issuances —  202  —  —  340  — 
Premiums received 6,030  4,776  21,662  6,297  8,216  2,044 
Policy charges (3,319) —  —  (3,474) —  — 
Surrenders and withdrawals (5,384) (43,533) (3,303) (5,280) (11,873) (2,805)
Benefit payments (7,844) (15,784) —  (8,999) (12,073) — 
Interest credited 7,135  7,560  1,238  7,170  8,290  1,125 
Other 2,177  258  (145) 3,195  662  292 
Balance at March 31,
$ 737,900  $ 907,797  $ 142,686  $ 744,244  $ 1,027,087  $ 100,124 

Weighted-average credit rate 3.92  % 3.29  % 3.78  % 3.91  % 3.26  % 4.58  %
Net amount at risk $ 1,847,128  N/A N/A $ 1,952,631  N/A N/A
Cash surrender value 676,247  907,797  142,686  693,201  1,027,064  100,124 

The following tables present the policyholders' account balances by range of guaranteed minimum crediting rates and the related range of difference, if any, in basis points between rates being credited to policy holders and the respective guaranteed minimums:
At March 31, 2023
Range of guaranteed minimum crediting rates
Interest Sensitive Life(1)
Deferred Annuity(1)
Other Policyholders' Funds(1)
At guaranteed minimum
Less than 3.00%
 $ —  $ 1,971  $ 43,191 
3.00%-3.99%
 28,956  698,952  4,097 
4.00%-4.99%
 619,411  206,874  57,596 
Greater than 5.00%
 89,533  —  37,802 
Total
$ 737,900  $ 907,797  $ 142,686 
(1)All of the Company's policyholders' account balances had actual crediting rates at the guaranteed minimum.

At March 31, 2022
Range of guaranteed minimum crediting rates
Interest Sensitive Life(1)
Deferred Annuity(1)
Other Policyholders' Funds(1)
At guaranteed minimum
Less than 3.00%
 $ —  $ 2,254  $ — 
3.00%-3.99%
 28,684  811,865  2,911 
4.00%-4.99%
 626,179  212,968  58,990 
Greater than 5.00%
 89,381  —  38,223 
Total
$ 744,244  $ 1,027,087  $ 100,124 
(1)All of the Company's policyholders' account balances had minimum crediting rates at the guaranteed minimum.
36
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 7—Deferred Acquisition Costs

The following tables roll forward the deferred policy acquisition costs for the three months ended March 31, 2023 and 2022:
Life
American Income DTC Liberty National Other Total
Balance at January 1, 2022
$ 1,960,254  $ 1,583,695  $ 566,419  $ 301,647  $ 4,412,015 
Capitalizations 114,428  48,216  20,465  3,487  186,596 
Amortization expense (33,513) (23,172) (11,046) (4,198) (71,929)
Foreign exchange adjustment 1,738  —  —  —  1,738 
Experience adjustment —  —  —  —  — 
Balance at March 31, 2022
$ 2,042,907  $ 1,608,739  $ 575,838  $ 300,936  $ 4,528,420 
Balance at January 1, 2023
$ 2,258,291  $ 1,676,931  $ 610,723  $ 298,346  $ 4,844,291 
Capitalizations 115,395  47,410  24,221  3,321  190,347 
Amortization expense (38,299) (24,753) (12,412) (4,125) (79,589)
Foreign exchange adjustment (2,787) —  —  —  (2,787)
Experience adjustment —  —  —  —  — 
Balance at March 31, 2023
$ 2,332,600  $ 1,699,588  $ 622,532  $ 297,542  $ 4,952,262 

Health
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2022
$ 81,140  $ 388,967  $ 127,537  $ 49,406  $ 2,032  $ 649,082 
Capitalizations 580  12,363  4,121  3,155  —  20,219 
Amortization expense (1,516) (6,405) (3,320) (829) (44) (12,114)
Foreign exchange adjustment —  —  —  88  —  88 
Experience adjustment —  —  —  —  —  — 
Balance at March 31, 2022
$ 80,204  $ 394,925  $ 128,338  $ 51,820  $ 1,988  $ 657,275 
Balance at January 1, 2023
$ 77,394  $ 416,608  $ 133,096  $ 57,811  $ 1,854  $ 686,763 
Capitalizations 507  15,097  4,882  3,143  —  23,629 
Amortization expense (1,513) (6,560) (3,250) (938) (47) (12,308)
Foreign exchange adjustment —  —  —  (126) —  (126)
Experience adjustment —  —  —  —  —  — 
Balance at March 31, 2023
$ 76,388  $ 425,145  $ 134,728  $ 59,890  $ 1,807  $ 697,958 
37
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents a reconciliation of deferred policy acquisition costs to the Consolidated Balance Sheets as of March 31, 2023:
March 31,
2023 2022
Life
American Income $ 2,332,600  $ 2,042,907 
Direct to Consumer 1,699,588  1,608,739 
Liberty National 622,532  575,838 
Other 297,542  300,936 
Total DAC - Life
4,952,262  4,528,420 
Health
United American 76,388  80,204 
Family Heritage 425,145  394,925 
Liberty National 134,728  128,338 
American Income 59,890  51,820 
Direct to Consumer 1,807  1,988 
Total DAC - Health
697,958  657,275 
Annuity
4,218  5,988 
Total
$ 5,654,438  $ 5,191,683 
38
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 8—Liability for Unpaid Claims

Activity in the liability for unpaid health claims is summarized as follows:
March 31,
2023		 December 31,
2022
Balance at beginning of period
$ 182,202  $ 171,109 
Incurred related to:
Current year 173,865  676,190 
Prior year (1,923) (15,631)
Total incurred 171,942  660,559 
Paid related to:
Current year 72,870  517,856 
Prior year 99,876  131,610 
Total paid 172,746  649,466 
Balance at end of period
$ 181,398  $ 182,202 

Below is the reconciliation of the liability of "Policy claims and other benefits payable" in the Consolidated Balance Sheets.
March 31,
2023		 December 31,
2022
Policy claims and other benefits payable:
Life insurance $ 307,898  $ 325,017 
Health insurance 181,398  182,202 
Total $ 489,296  $ 507,219 

39
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 9—Postretirement Benefits

Globe Life has qualified noncontributory defined benefit pension plans (Pension Plans) and contributory savings plans that cover substantially all employees. There is also a nonqualified noncontributory supplemental executive retirement plan (SERP) that covers a limited number of officers. The tables included herein will focus on the Pension Plans and SERP.

Pension Assets: The following table presents the assets of the Company's Pension Plans at March 31, 2023 and December 31, 2022.

Pension Assets by Component at March 31, 2023

  Fair Value Determined by:    
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total
Amount
 % of
Total
Corporate bonds:
Financial $ —  $ 22,482  $ —  $ 22,482  4 
Utilities —  20,838  —  20,838  4 
Energy —  7,564  —  7,564  2 
Other corporates —  26,433  —  26,433  5 
Total corporate bonds —  77,317  —  77,317  15 
Exchange traded fund(1)
 276,478  —  —  276,478  53 
U.S. Government and Agency —  76,643  —  76,643  15 
Other bonds —  202  —  202  — 
Guaranteed annuity contract(2)
 —  43,297  —  43,297  8 
Short-term investments 23,016  —  —  23,016  4 
Other 12,379  —  —  12,379  2 
$ 311,873  $ 197,459  $ —  509,332  97 
Other long-term investments(3)
 13,767  3 
Total pension assets
$ 523,099  100 
(1)A fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Included in other long-term investments is an investment fund that reports the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value per share or its equivalent (NAV), as a practical expedient for fair value. The Globe Life Inc. Pension Plan owns less than 1% of the investment fund. As of March 31, 2023, the expected term of the investment fund is approximately 2 years and the commitment of the investment is fully funded. The investment is non-redeemable.

40
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Pension Assets by Component at December 31, 2022
  Fair Value Determined by:    
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total
Amount
 % of
Total
Corporate bonds:
Financial $ —  $ 35,649  $ —  $ 35,649  7 
Utilities —  23,436  —  23,436  5 
Energy —  12,776  —  12,776  3 
Other corporates —  56,786  —  56,786  11 
Total corporate bonds —  128,647  —  128,647  26 
Exchange traded fund(1)
 258,297  —  —  258,297  52 
U.S. Government and Agency —  44,213  —  44,213  9 
Other bonds —  200  —  200  — 
Guaranteed annuity contract(2)
 —  43,116  —  43,116  8 
Short-term investments 4,467  —  —  4,467  1 
Other 6,547  —  —  6,547  1 
$ 269,311  $ 216,176  $ —  485,487  97 
Other long-term investments(3)
 14,288  3 
Total pension assets
$ 499,775  100 
(1)A fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Included in other long-term investments is an investment fund that reports the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value per share or its equivalent (NAV), as a practical expedient for fair value. The Globe Life Inc. Pension Plan owns approximately 1% of the investment fund. As of December 31, 2022, the expected term of the investment fund was approximately 3 years and the commitment of the investment is fully funded. The investment is non-redeemable.


SERP: The following table includes information regarding the SERP.
Three Months Ended
March 31,
2023 2022
Premiums paid for insurance coverage $ 443  $ 443 
March 31,
2023		 December 31,
2022
Total investments:
Company owned life insurance $ 54,788  $ 54,681 
Exchange traded funds 74,632  71,258 
$ 129,420  $ 125,939 


41
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Pension Plans and SERP Liabilities: The following table presents liabilities for the defined benefit pension plans and SERP at March 31, 2023 and December 31, 2022.
March 31,
2023		 December 31,
2022
Pension Plans $ 517,770  $ 492,103 
SERP 70,499  70,464 
Pension benefit obligation
$ 588,269  $ 562,567 

Net Periodic Benefit Cost: The following table presents the net periodic benefit costs for the Pension Plans and SERP by expense components for the three months ended March 31, 2023 and 2022.

Components of Net Periodic Benefit Cost
Three Months Ended
March 31,
  2023 2022
Service cost $ 5,392  $ 8,655 
Interest cost 7,834  6,123 
Expected return on assets (9,656) (8,885)
Amortization:
Prior service cost 269  158 
Actuarial (gain) loss (52) 3,209 
Net periodic benefit cost
$ 3,787  $ 9,260 


Note 10—Earnings Per Share

Earnings per Share: A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:
Three Months Ended
March 31,
2023 2022
Basic weighted average shares outstanding 96,388,211  99,273,616 
Weighted average dilutive options outstanding 1,522,889  976,758 
Diluted weighted average shares outstanding 97,911,100  100,250,374 
Antidilutive shares 209,870  563,991 

Antidilutive shares are excluded from the calculation of diluted earnings per share. 
42
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 11—Debt

The following table presents information about the terms and outstanding balances of Globe Life's debt.
 
Selected Information about Debt Issues
As of
March 31,
2023		 December 31,
2022
Instrument Issue Date Maturity Date Coupon Rate Par
Value		 Unamortized Discount & Issuance Costs Book
Value		 Fair
Value		 Book
Value
Senior notes 5/27/1993 5/15/2023 7.875% $ 165,612  $ (38) $ 165,574  $ 164,746  $ 165,500 
Senior notes 9/27/2018 9/15/2028 4.550% 550,000  (4,229) 545,771  546,348  545,601 
Senior notes 8/21/2020 8/15/2030 2.150% 400,000  (3,668) 396,332  323,984  396,219 
Senior notes(1)
 5/19/2022 6/15/2032 4.800% 250,000  (4,412) 245,588  241,275  245,493 
Junior subordinated debentures 11/17/2017 11/17/2057 5.275% 125,000  (1,585) 123,415  124,265  123,410 
Junior subordinated debentures 6/14/2021 6/15/2061 4.250% 325,000  (7,752) 317,248  248,300  317,229 
1,815,612  (21,684) 1,793,928  1,648,918  1,793,452 
Less current maturity of long-term debt 165,612  (38) 165,574  164,746  165,500 
Total long-term debt
1,650,000  (21,646) 1,628,354  1,484,172  1,627,952 
Current maturity of long-term debt 165,612  (38) 165,574  164,746  165,500 
FHLB borrowings 45,000  —  45,000  45,000  — 
Commercial paper 305,000  (1,327) 303,673  303,673  283,603 
Total short-term debt
515,612  (1,365) 514,247  513,419  449,103 
Total debt
$ 2,165,612  $ (23,011) $ 2,142,601  $ 1,997,591  $ 2,077,055 
(1)An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.

The commercial paper has the highest priority of all unsecured debt, followed by senior notes then junior subordinated debentures. The senior notes due 2023 are noncallable, the remaining senior notes are callable under a make-whole provision, and the junior subordinated debentures are subject to an optional redemption five years from issuance. Interest on the 4.25% junior subordinated debentures is payable quarterly while all other long-term debt is payable semi-annually.

Federal Home Loan Bank (FHLB): FHLB membership provides our insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. The membership requires ownership of FHLB common stock, as well as the purchase of activity-based common stock equal to approximately 4.1% of outstanding borrowings.

Globe Life owns $16.0 million in FHLB common stock as of March 31, 2023 and $14.3 million as of December 31, 2022. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments" in the Consolidated Balance Sheets.

Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of March 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $633 million, based on pledged assets with a fair value of $850 million.
43
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
As of March 31, 2023, $43 million in funding agreements were outstanding with the FHLB, compared to $23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" on the Consolidated Balance Sheets. In addition, the Company had $45 million in short-term borrowings from the FHLB as of March 31, 2023, compared to $0 as of December 31, 2022, and this amount is recorded in "Short-term debt" on the Consolidated Balance Sheets.


Note 12—Business Segments

Globe Life is organized into four segments: life insurance, supplemental health insurance, annuities, and investments. In addition, other expenses not included in these segments are reported in "Corporate & Other."

Globe Life's reportable insurance segments are based on the insurance product lines it markets and administers: life insurance, supplemental health insurance, and annuities. These major product lines are set out as reportable segments because of the common characteristics of products within these categories, comparability of margins, and the similarity in regulatory environment and management techniques. There is also an investment segment that manages the investment portfolio and cash flow for the insurance segments and the corporate function, which has been retrospectively adjusted to exclude the interest on deferred acquisition costs due to the adoption of ASU 2018-12 and the interest on debt. The Company's chief operating decision makers evaluate the overall performance of the operations of the Company in accordance with these segments.

Life insurance products marketed by Globe Life include traditional whole life and term life insurance. An immaterial amount of annuities sold as companion products are included in the life segment. Health insurance products are generally guaranteed renewable and include Medicare Supplement, critical illness, accident, and limited-benefit supplemental hospital and surgical coverage. Annuities include fixed-benefit contracts.

The following tables present segment premium revenue by each of Globe Life's distribution channels.

Premium Income by Distribution Channel
Three Months Ended March 31, 2023
  Life Health Annuity Total
Distribution Channel Amount % of
Total		 Amount % of
Total		 Amount % of
Total		 Amount % of
Total
American Income $ 387,512  50  $ 29,594  9  $ —  —  $ 417,106  38 
Direct to Consumer 247,667  32  17,248  5  —  —  264,915  24 
Liberty National 85,203  11  46,972  15  —  —  132,175  12 
United American 1,882  —  132,607  41  —  —  134,489  12 
Family Heritage 1,480  —  96,072  30  —  —  97,552  9 
Other 48,853  7  —  —  —  —  48,853  5 
$ 772,597  100  $ 322,493  100  $ —  —  $ 1,095,090  100 
44
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

  Three Months Ended March 31, 2022
  Life Health Annuity Total
Distribution Channel Amount
% of
Total
 Amount
% of
Total
 Amount
% of
Total
 Amount
% of
Total
American Income $ 370,106  49  $ 28,766  9  $ —  —  $ 398,872  37 
Direct to Consumer 245,732  33  17,928  6  —  —  263,660  25 
Liberty National 80,560  11  47,760  15  —  —  128,320  12 
United American 2,074  —  131,690  42  —  —  133,764  13 
Family Heritage 1,359  —  89,540  28  —  —  90,899  8 
Other 49,297  7  —  —  —  —  49,297  5 
$ 749,128  100  $ 315,684  100  $ —  —  $ 1,064,812  100 

Due to the nature of the life insurance industry, Globe Life has no individual or group that would be considered a major customer. Substantially all of Globe Life's business is conducted in the United States.
 
The measure of profitability established by the chief operating decision makers for the insurance segments is underwriting margin before other income and administrative expenses, in accordance with the manner in which the segments are managed. It essentially represents gross profit margin on insurance products before insurance administrative expenses and consists primarily of premium less net policy benefits, acquisition expenses, and commissions. Required interest on policy liabilities is reflected as a component of the Investment segment (rather than as a component of underwriting margin in the insurance and annuity segments) in order to match this cost with the investment income earned on the assets supporting the policy liabilities.
 
The measure of profitability for the Investment segment is excess investment income, representing the income earned on the investment portfolio in excess of policy requirements. During the implementation of ASU 2018-12, the Company reviewed its segment disclosures and modified the measure of profitability of our Investment Segment due to the adoption impact of the standard and to align more appropriately with how we view and measure this segment. As of January 1, 2023, this measure was retrospectively adjusted to exclude the interest on deferred acquisition costs due to the adoption of ASU 2018-12 and the interest expense on debt. Other than the above-mentioned interest allocations, no other intersegment revenues or expenses are recognized. Expenses directly attributable to corporate operations are included in the “Corporate & Other” category. Stock-based compensation expense is considered a corporate expense by Globe Life management and is included in this category. All other unallocated revenues and expenses on a pretax basis, including insurance administrative expense and interest on debt, are also included in the “Corporate & Other” segment category.
 
Globe Life holds a sizable investment portfolio to support its insurance liabilities, the yield from which is used to offset policy benefit, acquisition, administrative and tax expenses. This yield or investment income is taken into account when establishing premium rates and profitability expectations for its insurance products. From time to time, investments are sold or called, or experience a credit loss event, each of which is reflected by the Company as realized gain (loss)—investments. These gains or losses generally occur as a result of disposition due to issuer calls, compliance with Company investment policies, or other reasons often beyond management’s control. Unlike investment income, realized gains and losses are incidental to insurance operations, and only overall yields are considered when setting premium rates or insurance product profitability expectations. While these gains and losses are not relevant to segment profitability or core operating results, they can have a material positive or negative result on net income. For these reasons, management removes realized investment gains and losses when it views its segment operations.

Management removes items that are related to prior periods when evaluating the operating results of current periods. Management also removes non-operating items unrelated to the Company's core insurance activities when evaluating those results. Therefore, these items are excluded in its presentation of segment results because accounting guidance requires that operating segment results be presented as management views its business.
45
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
With the exception of the administrative settlements noted in the paragraphs above, all of these items are included in “Other operating expense” in the Condensed Consolidated Statements of Operations for the appropriate year. See additional detail below in the tables.

The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note 1—Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income.
Three Months Ended March 31, 2023
Life Health Annuity Investment Corporate & Other Adjustments Consolidated
Revenue:
Premium $ 772,597  $ 322,493  $ —  $ —  $ —  $ —  $ 1,095,090 
Net investment income —  —  —  257,105  —  —  257,105 
Other income —  —  —  —  50  —  50 
Total revenue 772,597  322,493  —  257,105  50  —  1,352,245 
Expenses:
Policy benefits 507,977  190,962  7,541  1,447  —  —  707,927 
Required interest on reserves (189,821) (26,323) (10,259) 226,403  —  —  — 
Amortization of acquisition costs 79,589  12,308  425  —  —  —  92,322 
Commissions, premium taxes, and non-deferred acquisition costs 83,578  54,214  5  —  —  —  137,797 
Insurance administrative expense(1)
 —  —  —  —  73,907  73,907 
Parent expense —  —  —  —  2,585  —  2,585 
Stock-based compensation expense —  —  —  —  7,679  —  7,679 
Interest expense —  —  —  —  24,867  —  24,867 
Total expenses 481,323  231,161  (2,288) 227,850  109,038  —  1,047,084 
Subtotal 291,274  91,332  2,288  29,255  (108,988) —  305,161 
Non-operating items —  —  —  —  —  — 
Measure of segment profitability (pretax)
$ 291,274  $ 91,332  $ 2,288  $ 29,255  $ (108,988) $ —  305,161 
Realized gain (loss)—investments (30,927)
Income before income taxes per Condensed Consolidated Statements of Operations
$ 274,234 
(1)Administrative expense is not allocated to insurance segments.




46
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Three Months Ended March 31, 2022
Life Health Annuity Investment Corporate & Other Adjustments Consolidated
Revenue:
Premium $ 749,128  $ 315,684  $ —  $ —  $ —  $ —  $ 1,064,812 
Net investment income —  —  —  244,894  —  —  244,894 
Other income —  —  —  —  164  —  164 
Total revenue 749,128  315,684  —  244,894  164  —  1,309,870 
Expenses:
Policy obligations 495,429  189,018  8,642  1,060  —  —  694,149 
Required interest on reserves (181,372) (25,270) (11,367) 218,009  —  —  — 
Amortization of acquisition costs 71,929  12,114  453  —  —  —  84,496 
Commissions, premium taxes, and non-deferred acquisition costs 73,548  51,952  9  —  —  —  125,509 
Insurance administrative expense(1)
 —  —  —  —  72,565  112  (2) 72,677 
Parent expense —  —  —  —  2,640  2,640 
Stock-based compensation expense —  —  —  —  9,035  —  9,035 
Interest expense —  —  —  —  19,944  —  19,944 
Total expenses 459,534  227,814  (2,263) 219,069  104,184  112  1,008,450 
Subtotal 289,594  87,870  2,263  25,825  (104,020) (112) 301,420 
Non-operating items —  —  —  —  —  112  (2) 112 
Measure of segment profitability (pretax)
$ 289,594  $ 87,870  $ 2,263  $ 25,825  $ (104,020) $ —  301,532 
Realized gain (loss)—investments (7,244)
Non-operating expenses (112)
Income before income taxes per Condensed Consolidated Statements of Operations
$ 294,176 
(1)Administrative expense is not allocated to insurance segments.
(2)Non-operating expenses.


Note 13—Subsequent Events

Subsequent to the balance sheet date, the Company closed on a $170 million delayed draw term loan in April 2023 with an 18-month term and a variable interest rate. The proceeds from the term loan will be used to retire the 7.875% Senior Notes maturing on May 15, 2023.

During the quarter, we reviewed available information to evaluate whether an expected credit loss allowance should be established related to our holdings of First Republic Bank. Based on our review, which included analyst reports, public company information, and investment and business news relative to current events, we determined no allowance was needed. Subsequent to March 31, 2023, it was announced First Republic Bank had entered receivership effective April 30, 2023. The Company had $38.6 million outstanding, at amortized cost, with First Republic Bank as of March 31, 2023 with no associated allowance for credit losses. As of May 9, 2023, the fair value of the investment in First Republic Bank was $0.4 million.




47
        GL Q1 2023 FORM 10-Q
Table of Contents
CAUTIONARY STATEMENTS
 
We caution readers regarding certain forward-looking statements contained in the foregoing discussion and elsewhere in this document, and in any other statements made by, or on behalf of Globe Life whether or not in future filings with the Securities and Exchange Commission. Any statement that is not a historical fact, or that might otherwise be considered an opinion or projection concerning the Company or its business, whether express or implied, is meant as and should be considered a forward-looking statement. Such statements represent management's opinions concerning future operations, strategies, financial results or other developments. We specifically disclaim any obligation to update or revise any forward-looking statement because of new information, future developments, or otherwise.
 
Forward-looking statements are based upon estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control, including uncertainties related to the impact of the COVID-19 pandemic and associated direct and indirect effects on our business operations, financial results, and financial condition. If these estimates or assumptions prove to be incorrect, the actual results of Globe Life may differ materially from the forward-looking statements made on the basis of such estimates or assumptions. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:
1.Economic and other conditions, including the impact of inflation, geopolitical events, and the COVID-19 pandemic on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;
2.Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);
3.Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;
4.Interest rate changes that affect product sales, financing costs, and/or investment portfolio yield;
5.General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from geopolitical events and the COVID-19 pandemic, particularly in certain industries that may comprise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;
6.Changes in the competitiveness of the Company's products and pricing;
7.Litigation results;
8.Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from operating during the COVID-19 pandemic and the impact of higher than anticipated inflation);
9.The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;
10.The customer response to new products and marketing initiatives;
11.Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12.Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;
13.The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity and demand for our products; and
14.Our ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.

Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission.
48
        GL Q1 2023 FORM 10-Q
Table of Contents
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 
The following discussion should be read in conjunction with Globe Life's Condensed Consolidated Financial Statements and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year.

The results included herein reflect the adoption of ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts. Globe Life Inc. implemented the standard on January 1, 2023 using the modified retrospective transition method at adoption. As a result of this election, the prior year figures have been retrospectively adjusted as of January 1, 2021 with significant impacts to Shareholders' Equity, underwriting margins and net operating income. While the impacts of the new accounting guidance is significant, we do not consider it a fundamental change to the overall business.

Additional information on the effects of the adoption has been included in Note 2—New Accounting Standards.

"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.


Results of Operations

icons2.jpg
How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life, supplemental health, and annuities, and the investment segment that supports the product lines. Segments are aligned based on their common characteristics, comparability of the profit margins, and management techniques used to operate each segment.
icons.jpg
Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further segmented by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below:
 Premium revenue
                                                           (Policy obligations)
                                                           (Policy acquisition costs and commissions)
                                                            Underwriting margin
icons3.jpg
Investment Segment. The investment segment involves the management of our capital resources, including investments and the management of liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below:
 Net investment income
(Required interest on policy liabilities)
                                                           Excess investment income

49
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Current Highlights, comparing year-to-date 2023 with 2022.
•Net income as a return on equity (ROE) for the three months ended March 31, 2023 was 22.9% and net operating income as an ROE, excluding accumulated other comprehensive income(1) was 14.6%.
•Total premium increased 3% over the same period in the prior year. Life premium increased 3% for the period from $749 million in 2022 to $773 million in 2023.
•Net investment income increased 5% over the same period in the prior year.
•Total net sales increased 5% over the same period in the prior year from $182 million in 2022 to $190 million in 2023. The average producing agent count across all of the exclusive agencies increased 7% over the prior year.
•Book value per share increased 56% over the same period in the prior year from $25.52 to $39.74. Book value per share, excluding accumulated other comprehensive income(1), increased 10% over the prior year from $63.91 in 2022 to $70.34 in 2023.
•For the three months ended March 31, 2023, the Company repurchased 1.2 million shares of Globe Life Inc. common stock at a total cost of $135 million for an average share price of $115.04.
The following graphs represent net income and net operating income for the three month periods ended March 31, 2023 and 2022.
1140 1142
(1)As shown in the charts above, net operating income is the consolidated total of segment profits after tax and as such is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. It differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding accumulated other comprehensive income (AOCI), is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI, net of tax, is $(3.0) billion and $(3.8) billion for the three months ended March 31, 2023 and 2022, respectively.
Book value per share, excluding AOCI, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(30.60) and $(38.39) for the three months ended March 31, 2023 and 2022, respectively.
Refer to Analysis of Profitability by Segment for non-GAAP reconciliation to GAAP.

50
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Summary of Operations. Net income declined 6% to $224 million during the three months ended March 31, 2023, compared with $237 million in the same period in 2022. This decrease was attributed to $24 million of after-tax realized losses on investments in the current period, as compared to $6 million of after tax realized losses on investments in the year-ago period. See further discussion under the caption Investments. On a diluted per common share basis, net income per common share for the three months ended March 31, 2023 declined 4% from $2.37 to $2.28.

Net operating income increased 2% to $248 million for the three months ended March 31, 2023, compared with $243 million for the same period in 2022, primarily due to a 5% increase in net investment income, offset by a 4% increase in required interest on policy liabilities, and a 1% increase in total underwriting margin. On a diluted per common share basis, net operating income per common share for the three months ended March 31, 2023 increased from $2.43 to $2.53, a 4% increase. Net operating income is the consolidated total of segment profits after tax and as such is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Additionally, net income in 2022 was affected by certain significant and unusual non-operating items. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods.

The Company continues to see positive signs in its core operations, including strong sales and premium growth, favorable persistency, and a strong ROE, excluding accumulated other comprehensive income.

51
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from GAAP net income primarily because it excludes certain non-operating items such as realized gains and losses and other significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

Analysis of Profitability by Segment
(Dollar amounts in thousands)
Three Months Ended March 31,
2023 2022 Change %
Life insurance underwriting margin $ 291,274  $ 289,594  $ 1,680  1 
Health insurance underwriting margin 91,332  87,870  3,462  4 
Annuity underwriting margin 2,288  2,263  25  1 
Excess investment income 29,255  25,825  3,430  13 
Other insurance:
Other income 50  164  (114) (70)
Administrative expense (73,907) (72,565) (1,342) 2 
Corporate and other (35,131) (31,619) (3,512) 11 
Pre-tax total 305,161  301,532  3,629  1 
Applicable taxes (57,119) (58,237) 1,118  (2)
Net operating income
248,042  243,295  4,747  2 
Reconciling items, net of tax:
Realized gain (loss)—investments (24,432) (5,723) (18,709)
Non-operating expenses —  (88) 88 
Net income
$ 223,610  $ 237,484  $ (13,874) (6)

The life insurance segment is our primary segment and is the largest contributor to earnings in each period presented. The life insurance segment underwriting margin increased $2 million compared with the prior year three-month period due to growth in premiums and lower net life claims as a percentage of premiums. The health segment contributed to the growth in income as well, contributing $91 million of underwriting margin in the first three months of 2023 compared with $88 million in the first three months of 2022.
52
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
In 2023, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was the American Income Life Division. The following charts represent the breakdown of total underwriting margin by operating segment and distribution channel for the three months ended March 31, 2023.
307308

Total premium income rose 3% for the three months ended March 31, 2023 to $1.1 billion. Total net sales increased 5% to $190 million, when compared with 2022. Total first-year collected premium (defined in the following section) was $146 million for 2023 and 2022.

Life insurance premium income increased 3% to $773 million over the prior-year total of $749 million. Life net sales rose 1% to $140 million for the first three months of 2023. First-year collected life premium declined 3% to $103 million. Life underwriting margins, as a percent of premium, declined to 38% in 2023 from 39%. Underwriting margin increased to $291 million in 2023, an increase of 1% over the same period in 2022, largely a result of an increase in premium growth.

Health insurance premium income increased 2% to $322 million over the prior-year total of $316 million. Health net sales rose 17% to $50 million for the first three months of 2023. First-year collected health premium rose 9% to $43 million. Health underwriting margins, as a percent of premium, were 28% in 2023 and 2022. Health underwriting margin increased to $91 million for the first three months of 2023, 4% over the same period in 2022.

Excess investment income, the measure of profitability of our investment segment, increased during the first three months of 2023 to $29.3 million from $25.8 million in the same period in 2022. Excess investment income per common share, reflecting the impact of our share repurchase program, increased 15% to $0.30 from $0.26 when compared with the same period in 2022.

Insurance administrative expenses increased 2% in 2023 when compared with the prior-year period. These expenses were 6.7% as a percent of premium during 2023 compared with 6.8% a year earlier.

For the three months ended March 31, 2023, the Company repurchased 1.2 million Globe Life Inc. shares at a total cost of $135 million for an average share price of $115.04.

53
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
The discussions of our segments are presented in the manner we view our operations, as described in Note 12—Business Segments.
 
We use three statistical measures as indicators of premium growth and sales over the near term: “annualized premium in force,” “net sales,” and “first-year collected premium.”
•Annualized premium in force is defined as the premium income that would be received over the following twelve months at any given date on all active policies if those policies remain in force throughout the twelve-month period.
•Net sales, a statistical performance measure, is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued.
•First-year collected premium is defined as the premium collected during the reporting period for all policies in their first policy year. First-year collected premium takes lapses into account in the first year when lapses are more likely to occur, and thus is a useful indicator of how much new premium is expected to be added to premium income in the future.

See further discussion of the distribution channels below for Life and Health.


54
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
LIFE INSURANCE

Life insurance is the Company's predominant segment. During 2023, life premium represented 71% of total premium and life underwriting margin represented 76% of the total underwriting margin. Additionally, investments supporting the reserves for life products produce the majority of excess investment income attributable to the investment segment.
 
The following table presents the summary of results of life insurance. Further discussion of the results by distribution channel is included below.

Life Insurance
Summary of Results
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2023 2022
Amount % of Premium Amount % of Premium Amount %
Premium and policy charges $ 772,597  100  $ 749,128  100  $ 23,469  3 
Policy obligations 507,977  66  495,429  66  12,548  3 
Required interest on reserves (189,821) (25) (181,372) (24) (8,449) 5 
Net policy obligations 318,156  41  314,057  42  4,099  1 
Commissions, premium taxes, and non-deferred acquisition expenses 83,578  11  73,548  10  10,030  14 
Amortization of acquisition costs 79,589  10  71,929  9  7,660  11 
Total expense 481,323  62  459,534  61  21,789  5 
Insurance underwriting margin
$ 291,274  38  $ 289,594  39  $ 1,680  1 

Net policy obligations amounted to 41% of premiums for the three months ended March 31, 2023, compared to 42% in the year-ago period.

The following table presents Globe Life's life insurance premium by distribution channel.

Life Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2023 2022
Amount % of Total Amount % of Total Amount %
American Income $ 387,512  50  $ 370,106  49  $ 17,406  5 
Direct to Consumer 247,667  32  245,732  33  1,935  1 
Liberty National 85,203  11  80,560  11  4,643  6 
Other 52,215  7  52,730  7  (515) (1)
Total
$ 772,597  100  $ 749,128  100  $ 23,469  3 

Annualized life premium in force was $3.11 billion at March 31, 2023, an increase of 4% over $2.99 billion a year earlier.

55
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

An analysis of life net sales, an indicator of new business production, by distribution channel is presented below. 

Life Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2023 2022
Amount % of Total Amount % of Total Amount %
American Income $ 83,329  59  $ 85,350  61  $ (2,021) (2)
Direct to Consumer 32,467  23  33,913  24  (1,446) (4)
Liberty National 21,979  16  17,365  13  4,614  27 
Other 2,594  2  2,375  2  219  9 
Total
$ 140,369  100  $ 139,003  100  $ 1,366  1 

First-year collected life premium by distribution channel is presented in the table below. 

Life Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
Three Months Ended March 31, Change
2023 2022
Amount % of Total Amount % of Total Amount %
American Income $ 63,758  62  $ 65,294  62  $ (1,536) (2)
Direct to Consumer 20,795  20  24,212  23  (3,417) (14)
Liberty National 15,795  16  13,748  13  2,047  15 
Other 2,263  2  2,397  2  (134) (6)
Total
$ 102,611  100  $ 105,651  100  $ (3,040) (3)

A discussion of life operations by distribution channel follows.

The American Income Life Division markets to members of labor unions and continues to diversify its lead sources by building relationships with other affinity groups, utilizing third-party internet vendor leads, and obtaining referrals to facilitate sustainable growth. This division is Globe Life's largest contributor to life premium of any distribution channel at 50% of the Company's March 31, 2023 total life premium. Net sales declined 2% to $83 million during the first three months of 2023, compared with $85 million during the same period in 2022. While first quarter sales declined slightly from a year ago, they grew 19% from the fourth quarter of last year. The underwriting margin, as a percent of premium, was 45% for the three months ended March 31, 2023, down from 47% in the year-ago period due to higher acquisition costs.

Below is the average producing agent count at the end of the period for the American Income Life Division. The average producing agent count is based on the actual count at the end of each week during the year. The average producing agent count increased 4% over the year-ago quarter and 3% over the fourth quarter of 2022. The increase in average producing agent count was driven by an increase in new agent recruiting. Sales growth in this division, as well as within our other exclusive agencies, is generally dependent on growth in the size of the agency force.

At March 31,
 Change
2023 2022 Amount %
American Income 9,714  9,385  329  4 
56
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis


American Income Life continues to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth and additional agency office openings. In addition to offering financial incentives and training opportunities, the agency has made considerable investments in information technology, including a customer relationship management (CRM) tool for the agency force. This tool is designed to drive productivity in lead distribution, conservation of business, manager dashboards and new agent recruiting. Additionally, this division has invested in and successfully implemented technology that allows the agency force to engage in virtual recruiting, training and sales activity. The agents have shifted to primarily a virtual experience with the customers and have generated a vast majority of sales through virtual presentations. We find this flexibility to be enticing for new recruits as well as a driver of sustainability for our agency force.

The Direct to Consumer Division (DTC) offers adult and juvenile life insurance through a variety of marketing approaches, including direct mailings, insert media, and electronic media. In recent years, production from electronic media, which is comprised of sales through both the internet and inbound phone calls to our call center, has grown faster than direct mail response as customer preferences increased marketing activity to internet and mobile technology. The proportion of sales from the internet and inbound phone calls continue to outpace the activity from the direct mailings, but all three channels continue to work in an OmniChannel approach. The different media channels support and complement one another in the division's efforts to reach the consumer. The DTC's long-term growth has been fueled by constant innovation and name recognition. We continually introduce new initiatives in this division in an attempt to increase response rates.

While the juvenile market is an important source of sales, it is also a vehicle to reach the parents and grandparents of juvenile policyholders, who are more likely to respond favorably to a DTC solicitation for life coverage on themselves in comparison to the general adult population. Also, future offerings to juvenile policyholders and their parents are sources of low acquisition-cost life insurance sales in the future.

DTC net sales declined 4% to $32 million for the three months ended March 31, 2023 compared with $34 million for the same period in the prior year. This decrease is primarily a result of the higher life net sales in the prior year ago period, which we are seeing return to pre-pandemic levels. The decline is also due in part to the impact of recent record inflation on the cost of our direct mailings and on our customers, who generally have less discretionary income to purchase and retain life insurance. DTC’s underwriting margin, as a percent of premium, was 23% for the three months ended March 31, 2023 compared with 24% for the same period in 2022. The decrease is primarily attributable to higher acquisition costs.

The Liberty National Division markets individual life insurance to middle-income household and worksite customers. Recent investments in new sales technologies as well as recent growth in middle management within the agency are expected to help continue this growth. The underwriting margin as a percent of premium was 32% for the three months ended March 31, 2023, down from 33% during the same period a year ago. The decrease is primarily attributable to higher acquisition costs in relation to premium during the three months ended March 31, 2023 compared with the same period a year ago.

Net sales rose 27% in the three months ended March 31, 2023 over the same period in 2022. With the division's ability to return to face-to-face customer interaction and the option of virtual sales, the Company continues to project total life net sales to increase for the remainder of 2023 as compared to the prior year.

Below is the average producing agent count at the end of the period for the Liberty National Division.
At March 31,
 Change
2023 2022 Amount %
Liberty National 3,011  2,656  355  13 

The Liberty National Division average producing agent count increased significantly compared with the prior-year comparable period. We continue to execute our long-term plan to grow this agency through expansion from small-town markets in the Southeast to more densely populated areas with larger pools of potential agent recruits and customers. In addition to the aforementioned geographic expansion, we have also started a campaign of market expansion to increase our agency presence in cities that we currently have offices, but not significant enough to properly serve the community, region, area and city.
57
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

These tend to be larger geographic cities which will help create long-term sustainable agency growth. Additionally, the agency continues to help improve the ability of agents to develop new worksite marketing business. Systems that have been put in place, including the addition of a CRM platform and enhanced analytical capabilities, help the agents develop additional worksite marketing opportunities as well as improve the productivity of agents selling in the individual life market. As the division continues to gain momentum in its sales and recruiting initiatives and advances its technology and CRM platform, the agency anticipates an increase in recruiting of new agents and an increase in the average producing agent count.

The other distribution channels primarily include non-exclusive independent agencies selling primarily life insurance. The other distribution channels contributed $52 million of life premium income, or 7% of Globe Life's total premium income in the three months ended March 31, 2023, and contributed 2% of net sales for the period.

HEALTH INSURANCE

Health insurance sold by the Company primarily includes Medicare Supplement insurance, accident coverage, and other limited-benefit supplemental health products including cancer, critical illness, heart, and intensive care coverage.

Health premium accounted for 29% of our total premium in 2023, while the health underwriting margin accounted for 24% of total underwriting margin. Health underwriting margin increased 4% to $91 million primarily due to higher premium growth. The Company continues to emphasize life insurance sales relative to health due to life’s superior long-term profitability and its greater contribution to excess investment income.

The following table presents underwriting margin data for health insurance.

Health Insurance
Summary of Results
(Dollar amounts in thousands)
  Three Months Ended March 31, Change
  2023 2022
  Amount % of
Premium		 Amount % of
Premium		 Amount %
Premium $ 322,493  100  $ 315,684  100  $ 6,809  2 
Policy obligations 190,962  59  189,018  60  1,944  1 
Required interest on reserves (26,323) (8) (25,270) (8) (1,053) 4 
Net policy obligations 164,639  51  163,748  52  891  1 
Commissions, premium taxes, and non-deferred acquisition expenses 54,214  17  51,952  16  2,262  4 
Amortization of acquisition costs 12,308  4  12,114  4  194  2 
Total expense 231,161  72  227,814  72  3,347  1 
Insurance underwriting margin
$ 91,332  28  $ 87,870  28  $ 3,462  4 

58
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Globe Life markets supplemental health insurance products through a number of distribution channels. The following table is an analysis of our health premium by distribution channel.

Health Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
(Decrease)
  2023 2022
Amount % of Total Amount % of Total Amount %
United American $ 132,607  41  $ 131,690  42  $ 917  1 
Family Heritage 96,072  30  89,540  28  6,532  7 
Liberty National 46,972  15  47,760  15  (788) (2)
American Income 29,594  9  28,766  9  828  3 
Direct to Consumer 17,248  5  17,928  6  (680) (4)
Total
$ 322,493  100  $ 315,684  100  $ 6,809  2 

Premium related to limited-benefit plans comprise $180 million, or 56%, of the total health premiums for 2023 compared with $173 million, or 55%, in the same period in the prior year. Premium from Medicare Supplement products comprises the remaining $142 million, or 44%, for 2023 compared with $143 million, or 45%, in the same period in the prior year.

Annualized health premium in force was $1.33 billion at March 31, 2023, an increase of 3% over $1.29 billion a year earlier.

Presented below is a table of health net sales by distribution channel.
 
Health Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
(Decrease)
  2023 2022
Amount % of Total Amount % of Total Amount %
United American $ 15,380  31  $ 12,970  30  $ 2,410  19 
Family Heritage 22,543  45  18,602  43  3,941  21 
Liberty National 7,096  14  6,214  15  882  14 
American Income 4,504  9  4,621  11  (117) (3)
Direct to Consumer 550  1  421  1  129  31 
Total
$ 50,073  100  $ 42,828  100  $ 7,245  17 

Health net sales related to limited-benefit plans comprise $38.4 million, or 77%, of the total health net sales for 2023 compared with $30.8 million, or 72%, in the same period in the prior year. Medicare Supplement sales make up the remaining $11.7 million, or 23%, for 2023 compared with $12.0 million, or 28%, in the same period in the prior year.

59
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table presents health insurance first-year collected premium by distribution channel.

 Health Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
(Decrease)
  2023 2022
Amount % of Total Amount % of Total Amount %
United American $ 15,096  35  $ 14,762  37  $ 334  2 
Family Heritage 17,200  40  14,668  37  2,532  17 
Liberty National 6,111  14  5,444  13  667  12 
American Income 4,117  9  4,323  11  (206) (5)
Direct to Consumer 814  2  691  2  123  18 
Total
$ 43,338  100  $ 39,888  100  $ 3,450  9 
 
First-year collected premium related to limited-benefit plans comprise $30 million, or 70%, of total first-year collected premium for 2023 compared with $26 million, or 65%, in the same period in the prior year. First-year collected premium from Medicare Supplement policies makes up the remaining $13 million, or 30%, for 2023 compared with $14 million, or 35%, in the same period in the prior year.

A discussion of health operations by distribution channel follows.
The United American Division consists of non-exclusive independent agencies who may also sell for other companies. The United American Division was Globe Life's largest health agency in terms of health premium income, with sales up 19% from the same period in the prior year period.
This division includes three different units:

•UA General Agency, which primarily sells individual Medicare Supplement insurance through independent agents;
•Special Markets, which markets retiree health insurance to employer and union group through brokers; and
•Globe Life Benefits, which offers group worksite supplemental health insurance through brokers.

While the increase in sales for this division was driven primarily by sales growth at Globe Life Benefits, the majority of the premium revenue comes from Medicare Supplement and Retiree Health business. Underwriting margin as a percent of premium for the division was flat at 10% for the three months ended March 31, 2023 and 2022.

The Family Heritage Division primarily markets limited-benefit supplemental health insurance in non-urban areas. Most of its policies include a cash-back feature, such as a return of premium, where any excess of premiums over claims paid is returned to the policyholder at the end of a specified period stated within the insurance policy. Underwriting margin as a percent of premium was 33% for the three months ended March 31, 2023, up from 31% in the same period last year.

60
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The division experienced a 21% increase in health net sales as compared with the three-month period a year ago, primarily due to an increase in recruiting, agent productivity and training. The division will continue to implement incentive programs to help drive an increase in productivity and the number of producing agents.

Below is the average producing agent count at the end of the period for the Family Heritage Division. The average producing agent count was up 18% compared with the same period a year ago, driven by a significant increase in recruiting during 2022 and 2023.
At March 31,
 Change
2023 2022 Amount %
Family Heritage Division 1,298  1,100  198  18 
The Liberty National Division represented 15% of all Globe Life health premium income for the three-month period ended March 31, 2023. The Liberty National Division markets limited-benefit supplemental health products, consisting primarily of critical illness insurance. Much of Liberty National's health business is generated through worksite marketing targeting small businesses. Health premium at Liberty National Division was $47 million for the three months ended March 31, 2023, and $48 million for the same period in 2022. Liberty National's first-year collected premium rose 12% to $6.1 million in the three months ended March 31, 2023 compared with $5.4 million for the same period in 2022. Health net sales for the three months ended March 31, 2023 rose 14% from the comparable period in 2022. The drivers of Liberty National's business discussed previously in the life insurance section also apply to the health business. Despite the increase in health sales from the prior year, health premiums were down slightly due to the run off of two older blocks of business that are no longer actively sold.

The Company's other distribution channels, while primarily focused on selling life insurance, also market health products. The American Income Life Division primarily markets accident plans. The Direct to Consumer Division primarily markets Medicare Supplements to employer or union-sponsored groups. On a combined basis, these other channels accounted for 14% of health premium for the three months ended March 31, 2023 compared with 15% for the same period in 2022.

ANNUITIES

Annuities represent an insignificant part of our business. We do not currently market stand-alone fixed or deferred annuity products, favoring instead protection-oriented life and supplemental health insurance products.

INVESTMENTS

We manage our capital resources, including investments and cash flow, through the investment segment. Excess investment income represents the profit margin attributable to investment operations and is the measure that we use to evaluate the performance of the investment segment as described in Note 12—Business Segments. It is defined as net investment income less the required interest attributable to policy liabilities.

Management also views excess investment income per diluted common share as an important and useful measure to evaluate the performance of the investment segment. It is defined as excess investment income divided by the total diluted weighted average shares outstanding, representing the contribution by the investment segment to the consolidated earnings per share of the Company. Since implementing our share repurchase program in 1986, we have used $9.1 billion of excess cash flow at the Parent Company to repurchase Globe Life Inc. common shares after determining that the repurchases provided a greater risk-adjusted after-tax return than other investment alternatives. If we had not used this excess cash to repurchase shares, but had instead invested it in interest-bearing assets, we would have earned more investment income and had more shares outstanding. As excess investment income per diluted common share incorporates all invested assets and insurance liabilities, we view excess investment income per diluted common share as a useful measure to evaluate the investment segment.

61
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Excess Investment Income. The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.

Analysis of Excess Investment Income
(Dollar amounts in thousands, except for per share data) 
 
Three Months Ended
March 31,		 Change
2023 2022 Amount %
Net investment income $ 257,105  $ 244,894  $ 12,211  5 
Interest on policy liabilities(1)
 (227,850) (219,069) (8,781) 4 
Excess investment income
$ 29,255  $ 25,825  $ 3,430  13 
Excess investment income per diluted share
$ 0.30  $ 0.26  $ 0.04  15 
Mean invested assets (at amortized cost) $ 20,147,812  $ 19,457,487  $ 690,325  4 
Average insurance policy liabilities 16,487,932  15,810,839  677,093  4 
(1)Interest on policy liabilities is a component of total policyholder benefits, a GAAP measure. The amounts presented for 2022 have been retrospectively adjusted to exclude the interest on deferred acquisition costs due to the LDTI standard and the interest on debt.

Excess investment income increased $3.4 million, or 13%, compared with the year-ago period. Excess investment income per diluted common share was $0.30 for the three months ended March 31, 2023, an increase of 15% over the prior-year period. Excess investment income per diluted common share generally increases at a faster pace than excess investment income because the number of diluted shares outstanding generally decreases from year to year as a result of our share repurchase program.

Net investment income for the three months ended March 31, 2023 was $257 million or 5% greater than the year-ago period. Mean invested assets increased 4% during the first three months of 2023 over the same period last year. The effective annual yield rate earned on the fixed maturity portfolio was 5.18% in the first three months of 2023, compared with 5.15% a year earlier. Investment income grew at a faster rate than the assets due to new investment yields exceeding the yield on dispositions and the average portfolio yield. We currently expect that the average annual turnover rate of fixed maturity assets will be less than 2% over the next five years and will not have a material impact on net investment income. In addition to fixed maturities, the Company has also invested in commercial mortgage loans and limited partnerships with debt like characteristics that diversify risk and enhance risk-adjusted, capital-adjusted returns on the portfolio. The earned yield on the investment funds for the three months ended March 31, 2023 was 5.87%. See additional information in Note 4—Investments. For the full year 2023, we currently anticipate the average new money rate on our fixed maturity acquisitions to be approximately 40 basis points higher than the yield achieved on our 2022 acquisitions. This expected increase in yields should result in the investment income growth rate being similar to the growth of our invested assets.

Globe Life's net investment income benefits from higher interest rates on new investments. While increasing interest rates have resulted in a net unrealized loss included in accumulated other comprehensive income (loss) as of March 31, 2023, we are not concerned because we do not generally intend to sell, nor is it likely that we will be required to sell, the fixed maturities prior to their anticipated recovery.

Required interest on insurance policy liabilities reduces excess investment income, as it is the amount of net investment income considered by management necessary to “fund” required interest on insurance policy liabilities. As such, it is removed from the investment segment and applied to the insurance segments to offset the effect of the required interest from the insurance segments. As discussed in Note 12—Business Segments, management regards this as a more meaningful analysis of the investment and insurance segments. Required interest is based on the original discount rate assumptions for our insurance policies in force.

The great majority of our life and health insurance policies are fixed interest rate protection policies, not investment products, and are accounted for under current GAAP accounting guidance for long-duration insurance products which mandate that interest rate assumptions for a particular block of business be “locked in” for the life of that block of business.
62
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Each calendar year, we set the original discount rate to be used to calculate the benefit reserve liability for all insurance policies issued that year. The liability reported on the balance sheet is updated in subsequent periods using current discount rates as of the end of the relevant reporting period with a corresponding adjustment to Other Comprehensive Income. The rates are based on the methodology prescribed in ASU 2018-12. See Note 1—Significant Accounting Policies for additional information.

The discount rate used for policies issued in the current year has no impact on the in-force policies issued in prior years as the rates of all prior issue years are also locked in for purposes of recognizing income. As such, the overall original discount rate for the entire in-force block of 5.5% is a weighted average of the discount rates being used from all issue years. Changes in the overall weighted-average discount rate over time are caused by changes in the mix of the reserves on the entire block of in force business. Business issued in the current year has little impact on the overall weighted-average original discount rate due to the size of our in-force business.

In comparison to the year-ago period, required interest on insurance policy liabilities increased $9 million, or 4%, to $228 million, compared with the 4% growth in average interest-bearing insurance policy liabilities.

Realized Gains and Losses. Our life and health insurance companies collect premium income from policyholders for the eventual payment of policyholder benefits, sometimes paid many years or even decades in the future. Since benefits are expected to be paid in future periods, premium receipts in excess of current expenses are invested to provide for these obligations. For this reason, we hold a significant investment portfolio as a part of our core insurance operations. This portfolio consists primarily of high-quality fixed maturities containing an adequate yield to provide for the cost of carrying these long-term insurance product obligations. As a result, fixed maturities are generally held for long periods to support these obligations. Expected yields on these investments are taken into account when setting insurance premium rates and product profitability expectations.

Despite our intent to hold fixed maturity investments for a long period of time, investments are occasionally sold, exchanged, called, or experience a credit loss event, resulting in a realized gain or loss. Gains or losses are only secondary to our core insurance operations of providing insurance coverage to policyholders. In a bond exchange offer, bondholders may consent to exchange their existing bonds for another class of debt securities. The Company also has investments in certain limited partnerships, held under the fair value option, with fair value changes recognized in Realized gains (losses) in the Condensed Consolidated Statements of Operations.

Realized gains and losses can be significant in relation to the earnings from core insurance operations, and as a result, can have a material positive or negative impact on net income. The significant fluctuations caused by gains and losses can cause period-to-period trends of net income that are not indicative of historical core operating results or predictive of the future trends of core operations. Accordingly, they have no bearing on core insurance operations or segment results as we view operations. For these reasons, and in line with industry practice, we remove the effects of realized gains and losses when evaluating overall insurance operating results.
63
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table summarizes our tax-effected realized gains (losses) by component.

Analysis of Realized Gains (Losses), Net of Tax
(Dollar amounts in thousands, except for per share data)
  Three Months Ended March 31,
  2023 2022
  Amount Per Share Amount Per Share
Fixed maturities:
Sales $ (283) $ —  $ (2,295) $ (0.02)
Matured or other redemptions(1)
 1  —  5,889  0.06 
Provision for credit losses (25,884) (0.26) 306  — 
Fair value option—change in fair value 1,468  0.01  (4,217) (0.04)
Other(2)
 266  —  (5,406) (0.06)
Total realized gains (losses)
$ (24,432) $ (0.25) $ (5,723) $ (0.06)
(1)During the three months ended March 31, 2023 and 2022, the Company recorded $0 and $0 of exchanges of fixed maturity securities (noncash transactions) that resulted in $0 and $0, respectively, in realized gains, net of tax.
(2)Other realized gains (losses) are primarily a result of changes in the fair value of exchange traded funds.

Investment Acquisitions. Globe Life's investment policy calls for investing primarily in investment grade fixed maturities that meet our quality and yield objectives. We generally invest in securities with longer-term maturities because they more closely match the long-term nature of our policy liabilities. We believe this strategy is appropriate since our expected future cash flows are generally stable and predictable and the likelihood that we will need to sell invested assets to raise cash is low.


64
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table summarizes selected information for fixed maturity investments. The effective annual yield shown is based on the acquisition price and call features, if any, of the securities. For non-callable bonds, the yield is calculated to maturity date. For callable bonds acquired at a premium, the yield is calculated to the earliest known call date and call price after acquisition ("first call date"). For all other callable bonds, the yield is calculated to maturity date.

Fixed Maturity Acquisitions Selected Information
(Dollar amounts in thousands)
Three Months Ended
March 31,
  2023 2022
Cost of acquisitions:
Investment-grade corporate securities $ 208,117  $ 187,324 
Investment-grade municipal securities 102,387  163,891 
Other investment-grade securities —  — 
Total fixed maturity acquisitions(1)
$ 310,504  $ 351,215 
Effective annual yield (one year compounded)(2)
 5.84  % 3.97  %
Average life (in years, to next call) 19.7  15.8 
Average life (in years, to maturity) 24.9  26.9 
Average rating A A
(1)Fixed maturity acquisitions included unsettled trades of $25 million in 2023 and $12 million in 2022.
(2)Tax-equivalent basis, where the yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.

For investments in callable bonds, the actual life of the investment will depend on whether the issuer calls the investment prior to the maturity date. Given our investments in callable bonds, the actual average life of our investments cannot be known at the time of the investment. Absent sales and "make-whole calls", however, the average life will not be less than the average life to next call and will not exceed the average life to maturity. Data for both of these average life measures is provided in the above chart.

Acquisitions in both periods consisted primarily of corporate and municipal bonds with securities spanning a diversified range of issuers, industry sectors, and geographical regions. In the first three months of 2023, we invested primarily in the municipal, financial and industrial sectors. For the entire portfolio, the taxable equivalent effective yield earned was 5.18%, up approximately 3 basis points from the yield in the first three months of 2022. Further, as previously noted in the discussion of net investment income, the increase in taxable equivalent effective yield was primarily due to new purchase yields exceeding the yield on dispositions and the average portfolio yield. For the remainder of 2023, the Company will continue to execute on its existing strategy by seeking to invest in assets that satisfy our quality and other objectives, while maximizing the highest risk-adjusted, capital-adjusted return.

65
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Since fixed maturities represent such a significant portion of our investment portfolio, the remainder of the discussion of portfolio composition will focus on fixed maturities. See a breakdown of the Company's Other long-term investments in Note 4—Investments.

Selected information concerning the fixed maturity portfolio is as follows:

Fixed Maturity Portfolio Selected Information
At
March 31,
2023		 December 31, 2022 March 31,
2022
Average annual effective yield(1)
 5.20% 5.19% 5.15%
Average life, in years, to:
Next call(2)
 14.6 14.7 15.5
Maturity(2)
 18.4 18.5 18.9
Effective duration to:
Next call(2,3)
 8.9 8.8 10.0
Maturity(2,3)
 10.5 10.4 11.5
(1)Tax-equivalent basis. The yield on tax-exempt securities is adjusted to produce a yield equivalent to the pre-tax yield on taxable securities.
(2)Globe Life calculates the average life and duration of the fixed maturity portfolio two ways:
(a) based on the next call date which is the next call date for callable bonds and the maturity date for noncallable bonds, and
(b) based on the maturity date of all bonds, whether callable or not.
(3)Effective duration is a measure of the price sensitivity of a fixed-income security to a 1% change in interest rates.

66
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Credit Risk Sensitivity. The following tables summarize certain information about the major corporate sectors and security types held in our fixed maturity portfolio at March 31, 2023 and December 31, 2022.

Fixed Maturities by Sector
March 31, 2023
(Dollar amounts in thousands)
Below Investment Grade Total Fixed Maturities % of Total Fixed Maturities
  Amortized
Cost, net 		Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 Amortized
Cost, net 		Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 At Amortized Cost, net At Fair Value
Corporates:
Financial
Insurance - life, health, P&C $ 107,271  $ —  $ (12,943) $ 94,328  $ 2,397,257  $ 58,903  $ (181,555) $ 2,274,605  13  13 
Banks 67,028  84  (17,173) 49,939  1,345,741  18,143  (100,741) 1,263,143  7  8 
Other financial 74,964  —  (22,346) 52,618  1,204,407  7,750  (171,098) 1,041,059  7  6 
Total financial 249,263  84  (52,462) 196,885  4,947,405  84,796  (453,394) 4,578,807  27  27 
Industrial
Energy 44,705  —  (10,416) 34,289  1,434,766  38,477  (80,338) 1,392,905  8  8 
Basic materials —  —  —  —  1,103,576  26,014  (74,413) 1,055,177  6  6 
Consumer, non-cyclical —  —  —  —  2,138,846  31,273  (166,382) 2,003,737  12  12 
Other industrials 57,979  3,053  (277) 60,755  1,206,816  30,521  (87,184) 1,150,153  6  6 
Communications 28,447  —  (2,610) 25,837  885,502  13,522  (87,212) 811,812  5  5 
Transportation —  —  —  —  531,796  18,925  (25,039) 525,682  3  3 
Consumer. cyclical 130,547  —  (19,805) 110,742  575,225  6,327  (65,777) 515,775  3  3 
Technology —  —  —  —  248,981  386  (51,383) 197,984  1  1 
Total industrial 261,678  3,053  (33,108) 231,623  8,125,508  165,445  (637,728) 7,653,225  44  44 
Utilities 35,493  456  (2,463) 33,486  1,958,888  70,798  (94,579) 1,935,107  10  11 
Total corporates
546,434  3,593  (88,033) 461,994  15,031,801  321,039  (1,185,701) 14,167,139  81  82 
States, municipalities, and political divisions:
General obligations —  —  —  —  923,669  9,243  (140,500) 792,412  5  5 
Revenues —  —  —  —  1,970,492  32,164  (286,429) 1,716,227  11  10 
Total states, municipalities, and political divisions —  —  —  —  2,894,161  41,407  (426,929) 2,508,639  16  15 
Other fixed maturities:
Government (U.S. and foreign) —  —  —  —  443,230  127  (38,764) 404,593  2  2 
Collateralized debt obligations 36,778  8,724  —  45,502  36,778  8,724  —  45,502  —  — 
Other asset-backed securities 12,387  —  (808) 11,579  87,966  4  (6,958) 81,012  1  1 
Total fixed maturities
$ 595,599  $ 12,317  $ (88,841) $ 519,075  $ 18,493,936  $ 371,301  $ (1,658,352) $ 17,206,885  100 100



67
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Fixed Maturities by Sector
December 31, 2022
(Dollar amounts in thousands)
Below Investment Grade Total Fixed Maturities % of Total Fixed Maturities
  Amortized
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 Amortized
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Value		 At Amortized Cost, net At Fair Value
Corporates:
Financial
Insurance - life, health, P&C $ 107,355  $ 22  $ (13,966) $ 93,411  $ 2,375,633  $ 44,578  $ (216,938) $ 2,203,273  13  13 
Banks 26,944  84  (192) 26,836  1,336,868  14,035  (100,038) 1,250,865  7  8 
Other financial 74,963  1  (22,026) 52,938  1,195,293  4,513  (187,513) 1,012,293  7  6 
Total financial 209,262  107  (36,184) 173,185  4,907,794  63,126  (504,489) 4,466,431  27  27 
Industrial
Energy 44,723  —  (10,168) 34,555  1,436,598  22,637  (101,923) 1,357,312  8  8 
Basic materials —  —  —  —  1,090,309  14,913  (95,958) 1,009,264  6  6 
Consumer, non-cyclical —  —  —  —  2,146,003  20,427  (232,196) 1,934,234  12  12 
Other industrials 25,461  —  (522) 24,939  1,212,674  19,107  (121,540) 1,110,241  6  7 
Communications 28,499  —  (2,253) 26,246  857,375  7,779  (110,132) 755,022  5  5 
Transportation —  —  —  —  520,029  11,684  (34,269) 497,444  3  3 
Consumer. cyclical 149,465  —  (27,822) 121,643  592,657  4,903  (85,005) 512,555  3  3 
Technology —  —  —  —  247,996  90  (59,672) 188,414  1  1 
Total industrial 248,148  —  (40,765) 207,383  8,103,641  101,540  (840,695) 7,364,486  44  45 
Utilities 35,496  433  (3,173) 32,756  1,924,190  36,670  (125,713) 1,835,147  11  11 
Total corporates 492,906  540  (80,122) 413,324  14,935,625  201,336  (1,470,897) 13,666,064  82  83 
States, municipalities, and political divisions:
General obligations —  —  —  —  915,725  5,041  (167,393) 753,373  5  5 
Revenues —  —  —  —  1,875,305  19,287  (338,054) 1,556,538  10  9 
Total states, municipalities, and political divisions —  —  —  —  2,791,030  24,328  (505,447) 2,309,911  15  14 
Other fixed maturities:
Government (U.S., municipal, and foreign) —  —  —  —  449,603  33  (51,674) 397,962  2  2 
Collateralized debt obligations 37,098  13,266  —  50,364  37,098  13,266  —  50,364  —  — 
Other asset-backed securities 12,493  —  (1,618) 10,875  88,336  4  (9,276) 79,064  1  1 
Total fixed maturities $ 542,497  $ 13,806  $ (81,740) $ 474,563  $ 18,301,692  $ 238,967  $ (2,037,294) $ 16,503,365  100 100



68
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Corporate securities, which consist of bonds and redeemable preferred stocks, were the largest component of the March 31, 2023 fixed maturity portfolio, representing 81% of amortized cost, net and 82% of fair value. The remainder of the portfolio is invested primarily in securities issued by the U.S. government and U.S. municipalities. The Company holds insignificant amounts in foreign government bonds, collateralized debt obligations, asset-backed securities, and mortgage-backed securities. Corporate securities are diversified over a variety of industry sectors and issuers. At March 31, 2023, the total fixed maturity portfolio consisted of 987 issuers.

Fixed maturities had a fair value of $17.2 billion at March 31, 2023, compared with $16.5 billion at December 31, 2022. The net unrealized loss position in the fixed-maturity portfolio decreased from $1.8 billion at December 31, 2022 to $1.3 billion at March 31, 2023 due to an increase in market rates during the period.

For more information about our fixed maturity portfolio by component at March 31, 2023 and December 31, 2022, including a discussion of allowance for credit losses, an analysis of unrealized investment losses and a schedule of maturities, see Note 4—Investments.

An analysis of the fixed maturity portfolio by a composite quality rating at March 31, 2023 and December 31, 2022, is shown in the following tables. The composite rating for each security, other than private-placement securities managed by third parties, is the average of the security’s ratings as assigned by Moody’s Investor Service, Standard & Poor’s, Fitch Ratings, and Dominion Bond Rating Service, LTD. The ratings assigned by these four nationally recognized statistical rating organizations are evenly weighted when calculating the average. The composite quality rating is created utilizing a methodology developed by Globe Life using ratings from the various rating agencies noted above. The composite quality rating is not a Standard & Poor's credit rating. Standard & Poor's does not sponsor, endorse, or promote the composite quality rating and shall not be liable for any use of the composite quality rating. Included in the following chart are private placement fixed maturity holdings of $455 million at amortized cost, net of allowance for credit losses ($420 million at fair value) for which the ratings were assigned by the third-party managers.

Fixed Maturities by Rating
At March 31, 2023
(Dollar amounts in thousands)
Amortized Cost, net % of Total Fair
Value		 % of Total Average Composite Quality Rating on Amortized Cost, net
Investment grade:
AAA $ 835,032  4  $ 763,470  5 
AA 2,884,448  16  2,462,806  14 
A 4,818,028  26  4,638,755  27 
BBB+ 3,978,836  22  3,795,423  22 
BBB 4,146,010  22  3,870,697  22 
BBB- 1,235,983  7  1,156,659  7 
Total investment grade
17,898,337  97  16,687,810  97  A-
Below investment grade:
BB 482,569  3  416,186  3 
B 70,344  —  51,482  — 
Below B 42,686  —  51,407  — 
Total below investment grade
595,599  3  519,075  3  BB-
$ 18,493,936  100  $ 17,206,885  100 
Weighted average composite quality rating
A-


69
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Fixed Maturities by Rating
At December 31, 2022
(Dollar amounts in thousands)
Amortized
Cost
 % of Total
Fair
Value
 % of Total Average Composite Quality Rating on Amortized Cost
Investment grade:
AAA $ 828,315  5  $ 733,524  4 
AA 2,779,587  15  2,260,257  14 
A 4,752,633  26  4,438,913  27 
BBB+ 3,934,053  21  3,639,118  22 
BBB 4,254,730  23  3,844,182  23 
BBB- 1,209,877  7  1,112,808  7 
Total investment grade
17,759,195  97  16,028,802  97  A-
Below investment grade:
BB 462,356  3  389,132  3 
B 43,044  —  35,067  — 
Below B 37,097  —  50,364  — 
Total below investment grade
542,497  3  474,563  3  BB-
$ 18,301,692  100  $ 16,503,365  100 
Weighted average composite quality rating
A-

The overall quality rating of the portfolio is A-, the same as year-end 2022. Fixed maturities rated BBB are 51% of the total portfolio at March 31, 2023, the same as year-end 2022. While this ratio is high relative to our peers, we have limited exposure to higher-risk assets such as derivatives, equities, and asset-backed securities. Additionally, the Company does not participate in securities lending and has no off-balance sheet investments as of March 31, 2023. Of our fixed maturity purchases, BBB securities generally provide the Company with the best risk-adjusted, capital-adjusted returns largely due to our ability to hold securities to maturity regardless of fluctuations in interest rates or equity markets.

An analysis of changes in our portfolio of below-investment grade fixed maturities at amortized cost, net of allowance for credit losses is as follows:

Below-Investment Grade Fixed Maturities
(Dollar amounts in thousands)
Three Months Ended
March 31,
2023 2022
Balance at beginning of period
$ 542,497  $ 701,546 
Downgrades by rating agencies 98,658  — 
Upgrades by rating agencies —  (96,080)
Dispositions (13,675) (23,041)
Provision for credit losses (32,767) (31)
Amortization and other 886  875 
Balance at end of period
$ 595,599  $ 583,269 

Our investment policy calls for investing primarily in fixed maturities that are investment grade and meet our quality and yield objectives. Thus, any increases in below-investment grade issues are typically a result of ratings downgrades of existing holdings. Below-investment grade bonds at amortized cost, net of allowance for credit losses, were 9% of our shareholders’ equity excluding accumulated other comprehensive income as of March 31, 2023.
70
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Globe Life invests long term and as such, one of our key criterion in our investment process is to select issuers that have the ability to weather multiple financial cycles.

OPERATING EXPENSES

Operating expenses are included in the "Corporate and Other" segment and are classified into two categories: insurance administrative expenses and expenses of the Parent Company. Insurance administrative expenses generally include expenses incurred after a policy has been issued. As these expenses relate to premium for a given period, management measures the expenses as a percentage of premium income. The Company also views stock-based compensation expense as a Parent Company expense. Expenses associated with the issuance of our insurance policies are reflected as acquisition expenses and included in the determination of underwriting margin.

An analysis of operating expenses is shown below.

Operating Expenses Selected Information
(Dollar amounts in thousands)
  Three Months Ended March 31, Increase
  2023 2022 (Decrease)
Amount % of
Premium		 Amount % of
Premium		 Amount %
Insurance administrative expenses:
Salaries $ 29,870  2.7  $ 30,283  2.8  $ (413) (1)
Other employee costs 9,413  0.9  11,276  1.1  (1,863) (17)
Information technology costs 14,249  1.3  12,899  1.2  1,350  10 
Legal costs 3,740  0.3  3,643  0.3  97  3 
Other administrative costs 16,635  1.5  14,464  1.4  2,171  15 
Total insurance administrative expenses 73,907  6.7  72,565  6.8  1,342  2 
Parent company expense 2,585  2,640  (55)
Stock compensation expense 7,679  9,035  (1,356)
Non-operating expenses —  112  (112)
$ 84,171  $ 84,352  $ (181) — 

Total operating expenses for March 31, 2023 were flat compared with the prior year. Insurance administrative expenses increased $1.3 million primarily due to higher information technology costs, information security costs, and other administrative costs offset by a decline in pension-related employee benefit costs. Insurance administrative expenses as a percent of premium were 6.7%, compared to 6.8% for the same period in 2022.

71
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

SHARE REPURCHASES

Globe Life has an ongoing share repurchase program that began in 1986, and is reviewed with the Board of Directors by management quarterly and annually reaffirmed by the Board of Directors. With no specified authorization amount, management determines the amount of repurchases based on the amount of the excess cash flows after the payment of dividends to the Parent Company shareholders, general market conditions, and other alternative uses. Excess cash flow at the Parent Company is primarily comprised of dividends received from the insurance subsidiaries less interest expense paid on its debt and other limited operating activities. The majority of our share repurchases are made from excess cash flow after the payment of shareholder dividends. Additionally, when stock options are exercised, proceeds from these exercises and the resulting tax benefit are used to repurchase additional shares on the open market to minimize dilution as a result of the option exercises. On August 10, 2022, the Board of Directors reauthorized the Parent Company’s share repurchase program in amounts and with timing that management, in consultation with the Board, determines to be in the best interest of the Company and its shareholders.
The following chart summarizes share repurchases for the three month periods ended March 31, 2023 and 2022.

Analysis of Share Repurchases
(Amounts in thousands, except per share data) 
  Three Months Ended March 31,
  2023 2022
  Shares Amount Average
Price		 Shares Amount Average
Price
Purchases with:
Excess cash flow at the Parent Company(1)
 1,176  $ 135,321  $ 115.04  880  $ 88,621  $ 100.70 
Option exercise proceeds 368  42,754  116.27  299  30,861  103.07 
Total 1,544  $ 178,075  $ 115.33  1,179  $ 119,482  $ 101.30 
(1)Excludes excise tax on the repurchase of treasury stock of $1.2 million for the three months ended March 31, 2023.
Throughout the remainder of this discussion, share repurchases will only refer to those made from excess cash flow at the Parent Company.

FINANCIAL CONDITION
 
Liquidity. Liquidity provides Globe Life with the ability to meet on demand the cash commitments required to support our business operations and meet our financial obligations. Our liquidity is primarily derived from multiple sources: positive cash flow from operations, a portfolio of marketable securities, a revolving credit facility, commercial paper and the Federal Home Loan Bank.

Insurance Subsidiary Liquidity. The operations of our insurance subsidiaries have historically generated substantial cash inflows in excess of immediate cash needs. Cash inflows for the insurance subsidiaries primarily include premium and investment income. In addition to investment income, maturities and scheduled repayments in the investment portfolio are cash inflows. Cash outflows from operations include policy benefit payments, commissions, administrative expenses, and taxes. A portion of the excess cash inflows in the current year will provide for the payment of future policy benefits and are invested primarily in long-term fixed maturities as they better match the long-term nature of these obligations. Excess cash available from the insurance subsidiaries’ operations is generally distributed as a dividend to the Parent Company, subject to regulatory restrictions. The dividends are generally paid in amounts equal to the subsidiaries’ prior year statutory net income excluding realized capital gains. While the leading source of the excess cash is investment income, a significant portion of the excess cash also comes from underwriting income due to our high underwriting margins and effective expense control. While the insurance subsidiaries annually generate more operating cash inflows than cash outflows, the companies also have the entire available-for-sale fixed maturity investment portfolio available to create additional cash flows if required.

72
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Four of our insurance subsidiaries are members of the FHLB of Dallas. FHLB membership provides the insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. While not the only source of liquidity, the FHLB could provide the insurance subsidiaries with an additional source of liquidity, if needed. Refer to Note 11—Debt for further details.

Parent Company Liquidity. An important source of Parent Company liquidity is the dividends from its insurance subsidiaries. These dividends are received throughout the year and are used by the Parent Company to pay dividends on common and preferred stock, interest and principal repayment requirements on Parent Company debt, and operating expenses of the Parent Company.
Three Months Ended
March 31,		 Twelve Months Ended December 31,
2023 2022 Projected 2023 2022
Liquidity Sources:
Dividends from Subsidiaries $ 129,725  $ 107,083  $ 470,000  $ 407,042 
Excess Cash Flows(1)
 104,440  69,270  345,000  278,434 
(1)Excess cash flows are reported net of shareholder dividends. For the three months ended March 31, 2023 and 2022, shareholder dividends were $20 million. For the twelve months ended December 31, 2023, we project approximately $84 million in shareholder dividends, consistent with the $81 million paid in 2022.

Dividends from subsidiaries and excess cash flows are projected to be higher in 2023 than in 2022 primarily due to lower life obligations and the growth in our underwriting margins, both of which resulted in higher statutory earnings generated by the affiliates. Additional sources of liquidity for the Parent Company are cash, intercompany receivables, intercompany borrowings, public debt markets, term loans, and a revolving credit facility. At March 31, 2023, the Parent Company had access to $77 million of invested cash, net intercompany receivables and other liquid assets.

Short-Term Borrowings. An additional source of Parent Company liquidity is a credit facility with a group of lenders allowing for unsecured borrowings and stand-by letters of credit up to $750 million, which could be extended up to $1 billion. While the Parent Company may request the extension, it is not guaranteed. Up to $250 million in letters of credit can be issued against the facility. The facility serves as a back-up line of credit for a commercial paper program under which commercial paper may be issued at any time, with total commercial paper outstanding not to exceed the facility maximum, less any letters of credit issued. Interest charged on the commercial paper program resembles variable rate debt due to its short term nature. On September 30, 2021, Globe Life amended the credit agreement dated August 24, 2020. The five-year credit agreement will now mature on September 30, 2026. As of March 31, 2023, the Parent Company was in full compliance with all covenants related to the aforementioned debt.

As a part of the credit facility, Globe Life has stand-by letters of credits. These letters of credit are issued on behalf of our insurance subsidiaries.

The following table presents certain information about our commercial paper borrowings.

Credit Facility—Commercial Paper
(Dollar amounts in thousands)
At
March 31,
2023		 December 31, 2022 March 31,
2022
Balance of commercial paper at end of period (par value) $ 305,000  $ 285,000  $ 372,524 
Annualized interest rate 5.28  % 4.78  % 0.69  %
Letters of credit outstanding $ 115,000  $ 125,000  $ 125,000 
Remaining amount available under credit line 330,000  340,000  252,476 

73
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Credit Facility—Commercial Paper Activity
(Dollar amounts in thousands)
  Three Months Ended March 31,
  2023 2022
Average balance of commercial paper outstanding during period (par value) $ 293,892  $ 426,243 
Daily-weighted average interest rate (annualized) 4.95  % 0.43  %
Maximum daily amount outstanding during period (par value) $ 477,700  $ 500,529 

The Company increased the commercial paper borrowings by $20 million since year-end. We had no difficulties in accessing the commercial paper market under this facility during the three months ended March 31, 2023 and 2022.

Globe Life expects to have readily available funds for 2023 and the foreseeable future to conduct its operations and to maintain target capital ratios in the insurance subsidiaries through liquid assets currently available, internally-generated cash flow and the credit facility. In the unlikely event that more liquidity is needed, the Parent Company could generate additional funds through multiple sources including, but not limited to, the issuance of debt, an additional short-term credit facility or term loan, and intercompany borrowing.

Consolidated Liquidity. Consolidated net cash inflows from operations were $477 million in the first three months of 2023, compared with $397 million in the same period of 2022. The increase is primarily attributable to fluctuations in the settlement of certain amounts included in other liabilities. In addition to cash inflows from operations, our insurance companies received proceeds from dispositions of fixed maturities available for sale in the amount of $62 million during the 2023 period. As previously noted under the caption Credit Facility, the Parent Company has in place a revolving credit facility. The insurance companies have no additional outstanding credit facilities.

Cash and short-term investments were $246 million at March 31, 2023, compared with $207 million at December 31, 2022. In addition to these liquid assets, $17.2 billion of fixed income securities are available for sale in the event of an unexpected need. Approximately $525 million, at fair value, are pledged for outstanding FHLB advances and reinsurance. Further, approximately 97% of our fixed income securities are publicly traded, freely tradable under SEC Rule 144, or qualified for resale under SEC Rule 144A. We generally expect to hold fixed income securities to maturity, and even though these securities are classified as available for sale, we have the ability and general intent to hold any securities to recovery. Our strong cash flows from operations, on-going investment maturities, and available liquidity under our credit facility make any need to sell securities for liquidity highly unlikely.

74
        GL Q1 2023 FORM 10-Q
Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Capital Resources. The Parent Company's capital structure consists of short-term debt (the commercial paper facility and current maturities of long-term debt), long-term debt, and shareholders’ equity.

Long-Term Borrowings. The outstanding long-term debt at book value was $1.6 billion at March 31, 2023 and $1.6 billion at December 31, 2022.

Selected Information about Debt Issues
As of March 31, 2023
(Dollar amounts in thousands)
Instrument Issue Date Maturity Date Coupon Rate   Interest Payment Dates Par
Value		 Book
Value		 Fair
Value
Senior notes 05/27/1993 05/15/2023 7.875% semiannual $ 165,612  $ 165,574  $ 164,746 
Senior notes 09/27/2018 09/15/2028 4.550% semiannual 550,000  545,771  546,348 
Senior notes 08/21/2020 08/15/2030 2.150% semiannual 400,000  396,332  323,984 
Senior notes(1)
 05/19/2022 06/15/2032 4.800% semiannual 250,000  245,588  241,275 
Senior notes 11/17/2017 11/17/2057 5.275%  semiannual 125,000  123,415  124,265 
Junior subordinated debentures 06/14/2021 06/15/2061 4.250% quarterly 325,000  317,248  248,300 
1,815,612  1,793,928  1,648,918 
Less current maturity of long-term debt 165,612  165,574  164,746 
Total long-term debt
1,650,000  1,628,354  1,484,172 
Current maturity of long-term debt 165,612  165,574  164,746 
FHLB borrowings 45,000  45,000  45,000 
Commercial paper 305,000  303,673  303,673 
Total short-term debt
515,612  514,247  513,419 
Total debt
$ 2,165,612  $ 2,142,601  $ 1,997,591 
(1)An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.

In April 2023, we closed on a $170 million delayed draw variable rate term loan with an 18-month term. The proceeds from the term loan will be used to retire the 7.875% Senior Notes maturing on May 15, 2023. Refer to Note 11—Debt for a complete analysis and description of long-term debt issues outstanding.

Financing costs for the corporate and other segment consist primarily of interest on our various debt instruments. The table below presents the components of financing costs and reconciles interest expense per the Condensed Consolidated Statements of Operations.

Analysis of Financing Costs
(Dollar amounts in thousands)
Three Months Ended
March 31,		 Increase
(Decrease)
2023 2022 Amount %
Interest on funded debt $ 20,244  $ 18,644  $ 1,600  9 
Interest on short-term debt 4,623  1,300  3,323  256 
Financing costs
$ 24,867  $ 19,944  $ 4,923  25 

During the first three months of 2023, financing costs increased 25% compared with the prior year. The increase in financing costs is primarily due to higher short-term interest rates. More information on our debt transactions is disclosed in the Financial Condition section of this report.

75
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis

Subsidiary Capital: The National Association of Insurance Commissioners (NAIC) has established a risk-based factor approach for determining threshold risk-based capital levels for all insurance companies. This approach was designed to assist the regulatory bodies in identifying companies that may require regulatory attention. A Risk-Based Capital (RBC) ratio is typically determined by dividing adjusted total statutory capital by the amount of risk-based capital determined using the NAIC’s factors. If a company’s RBC ratio approaches two times the RBC amount, the company must file a plan with the NAIC for improving its capital levels (this level is commonly referred to as “Company Action Level” RBC). Companies typically hold a multiple of the Company Action Level RBC depending on their particular business needs and risk profile.

Our goal is to maintain statutory capital within our insurance subsidiaries at levels necessary to support our current ratings. For 2023, Globe Life has targeted a consolidated Company Action Level RBC ratio of 300% to 320%. The Company concludes that this capital level is more than adequate and sufficient to support its current ratings, given the nature of its business and its risk profile. For 2022, our consolidated Company Action Level RBC ratio was 321%. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.

In August 2022, the NAIC fully adopted new and expanded C-2 life insurance mortality risk factors. The adoption of these factors resulted in higher amounts of required capital related to our life insurance liabilities. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.

Shareholders' Equity: In 2023, new guidance became effective that impacted the accounting for our long duration contracts with significant effects to shareholders' equity. Please see Note 2—New Accounting Standards for additional information.

Shareholders’ equity was $3.8 billion at March 31, 2023. This compares with $3.9 billion at December 31, 2022 and $2.5 billion at March 31, 2022, as adjusted. During the three months since December 31, 2022, shareholders’ equity decreased primarily due to a $171 million decline in AOCI as interest rates and discount rates have increased over the period. In addition, shareholders' equity increased by net income of $224 million during the first three months of 2023, but was offset by share repurchases of $135 million and an additional $43 million in share repurchases to offset the dilution from stock option exercises. On February 23, 2023, the Parent Company announced that it had declared a quarterly dividend of $0.2250 per share. This dividend was paid on May 1, 2023.

We plan to use excess cash available at the Parent Company as efficiently as possible in the future. Possible uses of excess cash flow include, but are not limited to, share repurchases, acquisitions, shareholder dividend payments, investments in securities, or repayment of short-term debt. We will determine the best use of excess cash after ensuring that targeted capital levels are maintained in our insurance subsidiaries. If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds..

As previously noted, the liability for future policy benefits under ASU 2018-12 is required to be computed using current discount rates with the impact of changes in discount rates included in accumulated other comprehensive income. Additionally, the guidance requires the liability for future policy benefits to be calculated using net premiums rather than gross premiums. Given that gross premiums are considerably higher than net premiums for our business, as seen in Note 6—Policy Liabilities, the measurement of the liability is higher than what it would be had it been computed using gross premiums. This is an important consideration when analyzing shareholders' equity.

Globe Life is required under GAAP to revalue its available for sale fixed maturity portfolio to fair market value at the end of each accounting period. These changes, net of their associated impact on deferred acquisition costs and income tax, are reflected directly in shareholders’ equity. Fluctuations in interest rates cause undue volatility in the period-to-period presentation of our shareholders’ equity, capital structure, and financial ratios. Due to the long-term nature of our fixed maturity investments and policy liabilities and the strong cash flows consistently generated by our insurance subsidiaries, we have the ability to hold our securities to maturity. As such, we do not expect to incur losses due to fluctuations in market value of fixed maturities caused by market rate changes and temporarily illiquid markets. Accordingly, our management, credit rating agencies, lenders, many industry analysts, and certain other financial statement users prefer to remove the effect of this accounting rule when analyzing our balance sheet, capital structure, and financial ratios.
76
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis

CRITICAL ACCOUNTING POLICIES

The following critical accounting policies were updated since the 2022 Form 10-K due to the adoption of ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (ASU 2018-12). Additional information on our accounting policies is disclosed in Note 1—Significant Accounting Policies.

Future Policy Benefits. The liability for future policy benefits for traditional and limited-payment long duration life and health products comprises approximately 91% of the total liability for future policy benefits. The liability is determined each reporting period based on the net level premium method. This method requires the liability for future policy benefits to be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders. Net level premiums reflect a recomputed net premium ratio using actual experience since the issue date or the Transition Date, and expected future experience. The liability is accrued as premium revenue is recognized and adjusted for differences between actual and expected experience. Long-duration insurance contracts issued by the Company are grouped into cohorts based on the contract issue year, distribution channel, legal entity and product type.

The Company reviews, and updates as necessary, its cash flow assumptions (mortality, morbidity, lapses and persistency) used to calculate the change in the liability for future policy benefits at least annually. These cash flow assumptions are reviewed at the same time every year, or more frequently, if suggested by experience. If cash flow assumptions are changed, the net premium ratio is recalculated from the original issue date, or the Transition Date, using actual experience and projected future cash flows. When the expected future net premiums exceed the expected future gross premiums, or the present value of future policyholder benefits exceeds the present value of expected future gross premiums, the liability for future policy benefits is adjusted with changes recognized in policyholder benefits on the Condensed Consolidated Statements of Operations. The cash flow assumptions do not include an adjustment for adverse deviation. Mortality tables used for individual life insurance include various industry tables and reflect modifications based on Company experience. Morbidity assumptions for individual health are based on Company experience and industry data. Lapse and persistency assumptions are based on Globe Life's experience.

The liability for future policy benefits is discounted using a current upper-medium grade fixed-income instrument yield that reflects the duration characteristics of the liability for future policy benefits. The discount rate assumption is updated each reporting period with the effect of the changes in the liability included in Other Comprehensive Income (OCI). The methodology for determining current discount rates consists of constructing a discount rate curve intended to be reflective of the currency and tenor of the insurance liability cash flows. The methodology is designed to prioritize observable inputs based on market data available in the local debt markets denominated in the same currency as the policies. For the discount rates applicable to tenors for which the single-A debt market is not liquid or there is little or no observable market data, the Company will use estimation techniques consistent with the fair value guidance in ASC 820. We further accrete interest as a component of policyholder benefits using the original discount rate that is locked-in during the year of contract issuance. The original discount rates (or the locked-in discount rates) are used for interest accretion purposes and for the determination of net premiums, whereas the current discount rates are used for purposes of valuing the liability.

The discount rate assumption is key in determining the change in the value of the liability for future benefits for long duration life and health contracts. Since the liability for future policy benefits for traditional and limited-payment long duration life and health products comprises approximately 91% of the total liability for future policy benefits, it is subject to interest rate risk. A decrease in discount rates will cause an increase in the obligation, and changes in assumptions may cause significant differences in results.


77
        GL Q1 2023 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis

The following table illustrates the interest rate risk sensitivity of our liability for future policy benefits as of March 31, 2023 and 2022. This table measures the effect of a parallel shift in discount rates on the liability. The data measures the change in reported value arising from an immediate change in rates in increments of 50 and 100 basis points, which would be recorded as a component of OCI.

Value of Liability for Future Policy Benefits
(Dollar amounts in thousands)
At March 31,
Change in Discount Rates(1)
 2023 2022
(200) $ 27,736,576  $ 32,550,308 
(100) 22,630,750  26,314,589 
(50) 20,624,391  23,859,913 
0 18,896,574  21,745,905 
50 17,399,322  19,915,180 
100 16,094,213  18,321,425 
200 13,942,344  15,701,262 
(1) In basis points.

Deferred Acquisition Costs. Certain costs of acquiring new insurance business are deferred and recorded as an asset. These costs are capitalized on a grouped contract basis and amortized over the expected term of the related contracts, and are essential for the acquisition of new insurance business. Deferred acquisition costs (DAC) are directly related to the successful issuance of an insurance contract, and primarily include sales commissions, policy issue costs, Direct to Consumer advertising costs, and underwriting costs. Additionally, DAC includes the value of business acquired (VOBA), which are the costs of acquiring blocks of insurance from other companies or through the acquisition of other companies. These costs represent the difference between the fair value of the contractual insurance assets acquired and liabilities assumed, compared against the assets and liabilities for insurance contracts that the Company issues or holds measured in accordance with GAAP.

DAC is amortized on a constant-level basis over the expected term of the grouped contracts, with the related expense included in amortization of deferred acquisition costs on the Condensed Consolidated Statements of Operations. The in-force metric used to compute the DAC amortization rate is annualized premium in force. The assumptions used to amortize acquisition costs include mortality, morbidity, and persistency. These assumptions will be reviewed at least annually and revised in conjunction with any change in the future policy benefit assumptions. The effect of changes in the assumptions will be recognized over the remaining expected contract term as a revision of future amortization amounts.

VOBA is amortized on a basis that is consistent with DAC, as described above, and is subject to periodic recoverability and loss recognition testing to determine if there is a premium deficiency. These tests evaluate whether the present value of future contract-related cash flows will support the capitalized VOBA asset. These cash flows consist primarily of premium income, less benefits and expenses. The present value of these cash flows, less the reserve liability, is then compared with the unamortized balance. In the event the estimated present value of net cash flows is less, the deficiency would be recognized by a charge to earnings and either a reduction of unamortized acquisition costs or an increase in the liability for future benefits.
78
        GL Q1 2023 FORM 10-Q
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
 
There have been no quantitative or qualitative changes with respect to market risk exposure during the three months ended March 31, 2023.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures: Globe Life Inc., under the direction of the Chief Executive Officers and the Executive Vice President and Chief Financial Officer, has established disclosure controls and procedures that are designed to ensure that information required to be disclosed by Globe Life in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The disclosure controls and procedures are also intended to ensure that such information is accumulated and communicated to Globe Life's management, including the Chief Executive Officers and the Executive Vice President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
 
As of the end of the fiscal quarter completed March 31, 2023, an evaluation was performed under the supervision and with the participation of Globe Life management, including the Chief Executive Officers and the Executive Vice President and Chief Financial Officer, of the disclosure controls and procedures (as those terms are defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon their evaluation, the Chief Executive Officers and the Executive Vice President and Chief Financial Officer have concluded that disclosure controls and procedures are effective as of the date of this Form 10-Q. In compliance with Section 302 of the Sarbanes Oxley Act of 2002 (18 U.S.C. § 1350), each of these officers executed a Certification included as an exhibit to this Form 10-Q.

Changes in Internal Control over Financial Reporting: During the period ended March 31, 2023 and in connection with the adoption of ASU 2018-12, the Company implemented additional processes and controls related to the accounting and disclosure of contracts impacted by the new standard for long duration life and health products and the other insurance liabilities. See Note 2—New Accounting Standards, Note 6—Policy Liabilities, and Note 7—DAC of the financial statements for additional information on the impacts of the adoption.

Otherwise, there have not been any changes to Globe Life Inc.'s internal control over financial reporting, or in other factors that could significantly affect the internal control over financial reporting subsequent to the date of their evaluation, which have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.
 
Part II—Other Information

Item 1. Legal Proceedings

Discussion regarding litigation and unclaimed property audits is provided in Note 5—Commitments and Contingencies.

79
        GL Q1 2023 FORM 10-Q
Table of Contents
Item 1A. Risk Factors
 
The Company had no material changes to its risk factors.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Certain Equity Securities by the Issuer and Others for the First Quarter of 2023
Period
(a) Total Number
of Shares
Purchased
(b) Average
Price Paid
Per Share
 (c) Total Number of
Shares Purchased as 
Part of Publicly Announced
Plans or Programs
(d) Maximum Number
of Shares (or
Approximate Dollar
Amount) that May
Yet Be Purchased
Under the Plans or
Programs
January 1-31, 2023 305,961  $ 119.84  305,961 
February 1-28, 2023 329,554  120.94  329,554 
March 1-31, 2023 908,522  111.78  908,522 

On August 10, 2022, the Globe Life Board of Directors reaffirmed its continued authorization of the Company's stock repurchase program in amounts and with timing that management, in consultation with the Board, determined to be in the best interest of the Company. The program has no defined expiration date or maximum shares to be repurchased.
80
        GL Q1 2023 FORM 10-Q
Table of Contents
Item 6. Exhibits
 
Exhibit No. Description
3.1
10.1
10.2
31.1
31.2
31.3
32.1
101.INS XBRL Instance Document- the instance document does not appear in the Interactive Data file because the XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).
*    Compensatory plan or arrangement.

81
        GL Q1 2023 FORM 10-Q
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
GLOBE LIFE INC.
Date: May 9, 2023 /s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer
Date: May 9, 2023 /s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer
Date: May 9, 2023 /s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and Chief Financial Officer

82
        GL Q1 2023 FORM 10-Q
EX-10.2 2 secondamendmenttoglobeli.htm EX-10.2 secondamendmenttoglobeli
















EX-31.1 3 a10-qex311dardenq1fy2023.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
I, J. Matthew Darden, certify that:
 
1.I have reviewed this quarterly report on Form 10-Q of Globe Life Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2023 /s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer


EX-31.2 4 a10-qex312svobodaq1fy2023.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
I, Frank M. Svoboda, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Globe Life Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2023 /s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer


EX-31.3 5 a10-qex313kalmbachq1fy2023.htm EX-31.3 Document

Exhibit 31.3
CERTIFICATIONS
I, Thomas P. Kalmbach, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Globe Life Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2023 /s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and Chief Financial Officer

EX-32.1 6 a10-qexhibit321all3q1fy2023.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION OF PERIODIC REPORT
We, J. Matthew Darden, Co-Chairman and Chief Executive Officer, Frank M. Svoboda, Co-Chairman and Chief Executive Officer, and Thomas P. Kalmbach, Executive Vice President and Chief Financial Officer, of Globe Life Inc., certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of our knowledge:
 
(1)the Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:  May 9, 2023

/s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer
/s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer
/s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and
Chief Financial Officer